<SEC-DOCUMENT>0001213900-21-066329.txt : 20211220
<SEC-HEADER>0001213900-21-066329.hdr.sgml : 20211220
<ACCEPTANCE-DATETIME>20211220161516
ACCESSION NUMBER:		0001213900-21-066329
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220208
FILED AS OF DATE:		20211220
DATE AS OF CHANGE:		20211220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38174
		FILM NUMBER:		211505410

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ea151669-def14a_citiuspharma.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0; width: 100%"><DIV STYLE="margin: 0; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy
Statement Pursuant to Section 14(a)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
the Securities Exchange Act of 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant</FONT>&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the Appropriate Box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
Proxy Statement</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9746;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
Proxy Statement</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
Additional Materials</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
Material Under Rule 14a-12</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citius
Pharmaceuticals, Inc.</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified in Its Charter)</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">&#9746;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fee required</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of each class of securities to which transaction applies:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
                                            number of securities to which transaction applies:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
                                            unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
                                            0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
                                            maximum aggregate value of transaction:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            fee paid:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
paid previously with preliminary materials:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">&#9744;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
                                            Previously paid:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form,
                                            Schedule or Registration Statement No.:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
                                            Party:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
                                            Filed:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citius
Pharmaceuticals, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11
Commerce Drive, 1st Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cranford,
NJ 07016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
Be Held on February 8, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the Annual Meeting of Stockholders of Citius Pharmaceuticals, Inc. The meeting will be held on February
8, 2022 at 8:00 a.m. (local time) at the Company&rsquo;s headquarters at 11 Commerce Drive, First Floor, Cranford, New Jersey 07016,
for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
elect seven directors to serve until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve on a non-binding advisory basis our executive compensation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            recommend, on an advisory basis, a three-year frequency with which the Company should conduct
                                            future stockholder advisory votes on our executive compensation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            ratify the selection of Wolf &amp; Company, P.C., an independent registered public accounting
                                            firm, as the auditor of the Company for the year ending September 30, 2022; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            transact such other business as may properly come before the meeting or any adjournment thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for the Annual Meeting is December 10, 2021. Only stockholders of record at the close of business on that date may vote at
the meeting or any adjournment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Myron Holubiak</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You are required to register in advance of the Annual Meeting if you
plan to attend the Annual Meeting in person. If you wish to register in advance of the Annual Meeting, please contact Jaime Bartushak
by no later than January 31, 2022, by e-mail (jbartushak@citiuspharma.com), telephone (908-967-6677 x103) or U.S. mail at 11 Commerce
Drive, 1<SUP>st</SUP> Floor, Cranford, New Jersey 07016.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
are cordially invited to attend the meeting in person. However, to assure your representation at the Annual Meeting, you are urged to
vote by proxy by following the instructions contained in the accompanying proxy statement. You may revoke your proxy in the manner described
in the proxy statement at any time before it has been voted at the Annual Meeting. Any stockholder attending the Annual Meeting may vote
in person even if he or she has returned a proxy. Please note, however, that if your shares are held of record by a broker, bank or other
nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. Your vote is important,
no matter how many shares you owned on the record date. Whether or not you plan to attend the Annual Meeting, we hope that you will vote
as soon as possible.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING TO BE HELD ON FEBRUARY 8, 2022.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
proxy statement and Annual Report on Form 10-K for the year ended September 30, 2021 are available at https://materials.proxyvote.com/17322U.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are pleased to take advantage of the Securities and Exchange Commission, or SEC, rules that allow us to furnish proxy materials, including
this notice, and the proxy statement (including an electronic proxy card for the meeting) for the Annual Meeting via the Internet. Taking
advantage of these rules allows us to lower the cost of delivering annual meeting materials to our stockholders and reduce the environmental
impact of printing and mailing these materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Citius
Pharmaceuticals, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11
Commerce Drive, 1st Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cranford,
NJ 07016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
2022 ANNUAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FEBRUARY
8, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement is furnished to stockholders in connection with the solicitation of proxies by the Board of Directors of Citius Pharmaceuticals,
Inc. (&ldquo;Citius&rdquo;, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo;, or &ldquo;us&rdquo;) in connection with the
2022 Annual Meeting of stockholders of the Company to be held on February 8, 2022 at 8:00 a.m. (local time) at the Company&rsquo;s headquarters
located at 11 Commerce Drive, First Floor, Cranford, New Jersey 07016 (the &ldquo;Annual Meeting&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the rules of the SEC, instead
of mailing a printed copy of our proxy materials to each stockholder of record, we are furnishing proxy materials, including the notice
of meeting, this proxy statement, and a proxy card for the meeting, by providing access to them on the Internet to save printing costs
and benefit the environment. These materials were first available on the Internet on or about December 20, 2021. We mailed a Notice of
Internet Availability of Proxy Materials on or about December 20, 2021 to our stockholders of record and beneficial owners as of December
10, 2021, the record date for the meeting. This proxy statement and the Notice of Internet Availability of Proxy Materials contain instructions
for accessing and reviewing our proxy materials on the Internet and for voting by proxy over the Internet. You will need to obtain your
own Internet access if you choose to access the proxy materials and/or vote over the Internet. If you prefer to receive printed copies
of our proxy materials, the Notice of Internet Availability of Proxy Materials contains instructions on how to request the materials by
mail. You will not receive printed copies of the proxy materials unless you request them. If you elect to receive the materials by mail,
you may also vote by proxy on the proxy card or voter instruction card that you will receive in response to your request. The proxy materials
and the accompanying Annual Report on Form 10-K are available at https://materials.proxyvote.com/17322U.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are taking precautions to protect those attending
the Annual Meeting from the coronavirus, or COVID-19. Attendees will be required to wear a mask. In addition, attendance at the Annual
Meeting may have to be limited due to the requirements of applicable laws or orders restricting the size of public gatherings or other
public health measures. To that end, you are required to register in advance of the Annual Meeting if you plan to attend the Annual Meeting
in person. If you wish to register in advance of the Annual Meeting, please contact Jaime Bartushak no later than January 31, 2022 by
email (jbartushak@citiuspharma.com), telephone (908-967-6677 x103) or U.S. mail at 11 Commerce Drive, 1<SUP>st</SUP> Floor, Cranford,
New Jersey 07016.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VOTING
SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
close of business on December 10, 2021 has been fixed as the record date for determination of the stockholders entitled to notice of,
and to vote at, the Annual Meeting. On that date there were outstanding and entitled to vote 146,029,630 shares of common stock, each
of which is entitled to one vote on each matter at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Company&rsquo;s bylaws the vote of a majority of shares of common stock either present in person or represented by proxy and entitled
to vote will be required to (i) elect directors, (ii) approve on a non-binding advisory basis our executive compensation, (iii) recommend,
on an advisory basis, a three-year frequency with which the Company should conduct future stockholder advisory votes on named executive
officer compensation, and (iv) ratify the selection of the independent auditors for the fiscal year ending September 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
presence, in person or by properly executed proxy, of the holders of shares of common stock entitled to cast a majority of all the votes
entitled to be cast at the Annual Meeting is necessary to constitute a quorum. Holders of shares of common stock represented by a properly
signed, dated and returned proxy will be treated as present at the Annual Meeting for purposes of determining a quorum. Proxies relating
to &ldquo;street name&rdquo; shares that are voted by brokers will be counted as shares present for purposes of determining the presence
of a quorum, but will not be treated as votes cast at the Annual Meeting as to any proposal as to which the brokers do not have voting
instructions or discretion to vote on routine matters. These missing votes are known as &ldquo;broker non-votes.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Cost
of this Proxy Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the cost of this proxy solicitation. In addition to soliciting proxies by mail, our directors and employees might solicit proxies
personally and by telephone. None of these individuals will receive any compensation for solicitation activities. We currently do not
plan to retain a proxy solicitor to assist in the solicitation of proxies, but were we to engage a proxy solicitor we would pay them
a fee. We will, upon request, reimburse banks, brokerage firms and other nominees for their expenses in sending proxy materials to their
principals and obtaining their proxies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>QUESTIONS
AND ANSWERS ABOUT THE ANNUAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
am I receiving these materials?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
mailed a Notice of Internet Availability of Proxy Materials and provided access to these proxy materials because the board of directors
of Citius Pharmaceuticals, Inc. is soliciting your proxy to vote at the 2022 Annual Meeting of stockholders. We invite you to attend
the Annual Meeting and request that you vote on the proposals described in this proxy statement. The meeting will be held on February
8, 2022 at 8:00 a.m. (local time) at the Company&rsquo;s headquarters located at 11 Commerce Drive, First Floor, Cranford, New Jersey
07016. However, you do not need to attend the meeting to vote your shares. Instead, you may follow the instructions in the Notice of
Internet Availability of Proxy Materials to vote via the Internet, by telephone or by mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
do I attend the Annual Meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are taking precautions to protect those attending
the Annual Meeting from the coronavirus, or COVID-19. Attendees will be required to wear a mask. In addition, attendance at the Annual
Meeting may have to be limited due to the requirements of applicable laws or orders restricting the size of public gatherings or other
public health measures. To that end, you are required to register in advance of the Annual Meeting if you plan to attend the Annual Meeting
in person. If you wish to register in advance of the Annual Meeting, please contact Jaime Bartushak no later than January 31, 2022 by
email (jbartushak@citiuspharma.com), telephone (908-967-6677 x103) or U.S. mail at 11 Commerce Drive, 1<SUP>st</SUP> Floor, Cranford,
New Jersey 07016.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
can vote at the Annual Meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
stockholders of record at the close of business on December 10, 2021, the record date for the Annual Meeting, will be entitled to vote
at the Annual Meeting. On December 10, 2021, there were 146,029,630 shares of common stock (each entitled to one vote) outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
of Record: Shares Registered in Your Name</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
on December 10, 2021, your shares of our common stock were registered directly in your name with our transfer agent, Vstock Transfer,
LLC, then you are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting, or vote by proxy
via the Internet, by telephone, or by mail. Whether or not you plan to attend the meeting, we urge you to vote, in whatever manner you
prefer, to ensure your vote is counted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Beneficial
Owner: Shares Registered in the Name of a Broker or Bank</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
on December 10, 2021, your shares of our common stock were held in an account at a brokerage firm, bank, dealer or other similar organization,
then you are the beneficial owner of shares held in &ldquo;street name&rdquo; and these proxy materials are being forwarded to you by
that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual
Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You
are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares in
person at the Annual Meeting unless you request and obtain a signed letter or other valid proxy from your broker or other agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
am I voting on?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are three matters scheduled for a vote at the Annual Meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            elect seven directors to serve until the 2023 Annual Meeting of Stockholders or until their
                                            successors are duly elected and qualified;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            approve on a non-binding advisory basis our executive compensation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommend,
                                            on an advisory basis, a three-year frequency with which the Company should conduct future
                                            stockholder advisory votes on our executive compensation; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            ratify the selection of Wolf &amp; Company, P.C., an independent registered public accounting
                                            firm, as the auditor of the Company for the fiscal year ending September 30, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will also consider any other business that properly comes before the meeting. As of the record date, we are not aware of any other matters
to be submitted for consideration at the meeting. If any other matters are properly brought before the meeting, the persons named in
the proxy card or voter instruction card will vote the shares they represent using their best judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
many votes do I have?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
each matter to be voted upon, you have one vote for each share of common stock you owned as of December 10, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
is the quorum requirement?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of our outstanding shares of common stock entitled to vote as of the record date must be present at the Annual Meeting in order for us to hold the meeting and conduct business. This is called a quorum. Your shares will be counted as present
at the Annual Meeting if you:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are
present and entitled to vote in person at the Annual Meeting;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">properly
                                            submitted a proxy card or voter instruction card in advance of or at the Annual Meeting;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
                                            not provide your broker with instructions on how to vote, but the broker submits the proxy
                                            nonetheless (a broker non-vote).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are present in person or by proxy at the Annual Meeting, but abstain from voting on any or all proposals, your shares are still counted
as present and entitled to vote. The proposals listed in this proxy statement identify the votes needed to approve or ratify the proposed
actions. See also <I>&ldquo;How many votes are needed to approve each Proposal?&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
do I vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
procedures for voting are set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stockholder
of Record: Shares Registered in Your Name</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy via the Internet, by telephone or by mail.
Whether or not you plan to attend the Annual Meeting, we urge you to vote, in whatever manner you prefer, to ensure your vote is counted.
You may still attend the Annual Meeting and vote in person if you have already voted via the Internet, by telephone or by mail. You may
vote as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
                                            the Internet by accessing the proxy materials on the secure website https://www.proxyvote.com
                                            and following the voting instructions on that website;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via
                                            telephone by calling toll free 1-800-690-6903 in the United States or outside the United
                                            States and following the recorded instructions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
                                            requesting that printed copies of the proxy materials be mailed to you pursuant to the instructions
                                            provided in the Notice of Internet Availability of Proxy Materials and completing, dating,
                                            signing and returning the proxy card that you receive in response to your request; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            vote in person, register for and attend the Annual Meeting and we will give you a ballot
                                            when you arrive.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Beneficial
Owner: Shares Registered in the Name of Broker or Bank</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares in &ldquo;street name&rdquo; and thus are a beneficial owner of shares registered in the name of your broker, bank
or other agent, you must vote your shares in the manner prescribed by your broker or other nominee. Your broker or other nominee has
provided to you a voting instruction card for you to use in directing the broker or nominee how to vote your shares. Check the voting
form used by that organization to see if it offers internet or telephone voting. To vote in person at the Annual Meeting, you must obtain
a valid proxy from your broker, bank or other agent. Follow the instructions from your broker or bank included with these proxy materials,
or contact your broker or bank to request a proxy form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
are votes counted?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may vote &ldquo;FOR&rdquo;, &ldquo;AGAINST&rdquo;, &ldquo;ABSTAIN&rdquo; or &ldquo;WITHHOLD&rdquo;, as the case may be, to (i) elect
seven directors to serve until the 2023 Annual Meeting of Stockholders; (ii) approve on a non-binding advisory basis our executive compensation;
(iii) recommend, on an advisory basis, a three-year frequency with which the Company should conduct future stockholder advisory votes
on our executive compensation; and (iv) ratify the selection of Wolf &amp; Company, P.C., an independent registered public accounting
firm, as the auditor of the Company for the fiscal year ending September 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you mail your proxy, vote via the Internet or by telephone, but withhold or abstain from voting on one or more matters, your shares will
be counted as present at the Annual Meeting for the purpose of determining a quorum. Your shares also will be counted as present at the
meeting for the purpose of calculating the vote on the particular matter with respect to which you withheld or abstained from voting.
If you abstain or withhold from voting on a proposal, your abstention or withheld vote has the same effect as a vote against that proposal.
See <I>&ldquo;How many votes are needed to approve each Proposal?&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares in street name and do not provide voting instructions to your brokerage firm, your brokerage firm may still be able
to vote your shares with respect to &ldquo;discretionary&rdquo; (or routine) items, but it will not be allowed to vote your shares with
respect to &ldquo;non-discretionary&rdquo; items. In the case of non-discretionary items, for which no instructions are received, the
shares will be treated as &ldquo;broker non-votes&rdquo;. Shares that constitute broker non-votes will be counted as present at the Annual
Meeting for the purpose of determining a quorum, but will not be considered entitled to vote on the proposal in question. Your broker
does not have discretionary authority to vote shares for the election of directors, for the approval on a non-binding advisory basis
of our executive compensation or for the recommendation, on an advisory basis, of a three-year frequency with which we should conduct
future stockholder advisory votes on our executive compensation, but will have discretionary authority to vote on the proposal relating
to the ratification of the selection of the accounting firm. As a result, if you do not vote your street name shares, your broker has
the authority to vote on your behalf with respect to Proposal 3 (the ratification of the selection of the accounting firm).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
many votes are needed to approve each Proposal?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 62%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposal</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0; width: 1%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
    Required</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0; width: 1%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 14%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretionary</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
    Allowed</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of seven members to our Board of Directors</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    majority of the votes represented at the meeting and entitled to vote.</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
on a non-binding advisory basis of our executive compensation</FONT></P></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the votes represented at the meeting and entitled to vote.</FONT></P></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation,
on an advisory basis, a three-year frequency with which the Company should conduct future stockholder advisory votes on our executive
compensation&nbsp;</FONT></P></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of the votes represented at the meeting and entitled to vote.</FONT></P></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratification
    of the selection of Wolf &amp; Company, P.C., an Independent Registered Public Accounting Firm, as the auditor for our Fiscal Year
    Ending September 30, 2022</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    majority of the votes represented at the meeting and entitled to vote.</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Can
I change my vote after submitting my proxy, voting via the Internet or by telephone?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are a stockholder of record, you may revoke
your proxy in any one of four ways:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you voted by telephone or via the Internet, voting again by the same means prior to 11:59
                                            PM Eastern Time on February 8, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may submit another properly completed proxy card with a later date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may send a written notice that you are revoking your proxy to our Corporate Secretary, Citius
                                            Pharmaceuticals, Inc., 11 Commerce Drive, 1<SUP>st</SUP> Floor, Cranford, New Jersey 07016.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may register for and attend the Annual Meeting and vote in person. Simply attending the Annual
                                            Meeting will not, by itself, revoke your proxy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a beneficial owner of shares, you may submit new voting instructions by contacting your bank, broker, or other holder of record.
You may also vote in person at the Annual Meeting if you obtain a legal proxy from them as described in the answer to a previous question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>How
can I find out the results of the voting at the Annual Meeting?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
voting results will be announced at the Annual Meeting. Final voting results will be published in a Current Report on Form 8-K within
four business days after the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
does it mean if I receive more than one Notice of Internet Availability of Proxy Materials?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you receive more than one Notice of Internet Availability of Proxy Materials, your shares are registered in more than one name or are
registered in different accounts. Please vote your shares via the Internet, by telephone or by mail for each Notice of Internet Availability
of Proxy Materials you received to ensure that all of your shares are voted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Who
is paying for this proxy solicitation?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the expenses involved in preparing, assembling and mailing the proxy materials and all costs of soliciting proxies will be paid by
us. In addition to the delivery of the Notice of Internet Availability of Proxy Materials, our directors, officers and employees may
also solicit proxies in person, by telephone, by facsimile, by electronic mail or by other means of communication. We will not pay our
directors, officers and employees any compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents
for the cost of forwarding proxy materials to beneficial owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ELECTION
OF DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that the number of directors constituting the Board of Directors shall be not less than six and may consist of such larger
number as may be determined from time to time by the Board. The Board has set the number of directors at seven. There are seven directors
presently serving on our Board, and the number of directors to be elected at the Annual Meeting is seven. Each elected director will
serve until the Company&rsquo;s 2023 Annual Meeting of Stockholders or until a successor is elected and qualified. All of the nominees
currently serve on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has determined that directors Suren Dutia, Carol Webb, Dr. William Kane, Howard Safir and Dr. Eugene Holuka are independent
under the applicable NASDAQ listing standards. The Board has determined that director Leonard Mazur, the Executive Chairman and Secretary,
and Myron Holubiak, the Chief Executive Officer and President, are not independent under that definition due to being employed by the
Company. In addition to the specific bars to independence set forth in the applicable rules, we also consider whether a director or his
or her affiliates have provided any services to, worked for or received any compensation from us or any of our subsidiaries in the past
three years. None of the nominees is related by blood, marriage or adoption to any other nominee or any of our executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
nominees have consented to serve if elected. We expect that each of the nominees will be available for election, but if any of them is
not a candidate at the time the election occurs, a proxy will be voted for the election of another nominee to be designated by the Board
to fill any such vacancy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Biographical
and certain other information concerning the Company&rsquo;s nominees for election to the Board of Directors is set forth below. Except
as indicated below, none of our directors is a director in any other reporting company. We are not aware of any proceedings to which
any of our directors or any associate of any such director is a party adverse to us or any of our subsidiaries or has a material interest
adverse to us or any of our subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Nominees with Terms Expiring in 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth information concerning our director nominees as of November 30, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; width: 49%; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0; width: 49%; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Myron
    Holubiak</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leonard
    Mazur</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren
    Dutia</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carol
    Webb</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    William Kane</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
    Safir</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Eugene Holuka</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Myron
Holubiak</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Myron
Holubiak is the President, Chief Executive Officer and has been a member of the Board since October 2015. Mr. Holubiak also serves as
the acting Chief Executive Officer of our majority-owned subsidiary, NoveCite, Inc. Mr. Holubiak has extensive experience in managing
and advising large and emerging pharmaceutical and life sciences companies. Mr. Holubiak was the President of Roche Laboratories, Inc.
(&ldquo;Roche&rdquo;), a major research-based pharmaceutical company, from December 1998 to August 2001. Prior to that, he held sales
and marketing positions at Roche during his 19-year tenure. From September 2002 to July 2016, Mr. Holubiak served on the board of directors
and for the last two years was the Chairman of the board of directors of BioScrip, Inc. (&ldquo;BioScrip&rdquo;) (Nasdaq: BIOS). BioScrip
is a leading national provider of infusion and home care management solutions. Since July 2010, Mr. Holubiak has served as a member of
the board of directors of Assembly Biosciences, Inc. (&ldquo;Assembly&rdquo;) (Nasdaq: ASMB) and its predecessor Ventrus Biosciences,
Inc. Assembly is a biopharmaceutical company developing innovative treatments for hepatitis B virus infection (HBV) and C. difficile-associated
diarrhea (CDAD). Additionally, Mr. Holubiak serves as a director for bioAffinity Technologies Inc., a privately held company. In March
2013, Mr. Holubiak founded Leonard-Meron Biosciences, Inc. (&ldquo;LMB&rdquo;), the Company&rsquo;s wholly-owned subsidiary, and he served
as the Chief Executive Officer and President of LMB until March 2016. In addition, Mr. Holubiak was also a trustee of the Academy of
Managed Care Pharmacy Foundation from April 2013 to April 2015. Mr. Holubiak received a B.S. in Molecular Biology and Biophysics from
the University of Pittsburgh; he received advanced business training from the Harvard Business School and the University of London; and
advanced training in health economics from the University of York&rsquo;s Centre for Health Economics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Mr. Holubiak is qualified to serve as a director because of his industry knowledge and experience managing both large
and small pharmaceutical companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leonard
Mazur</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leonard
Mazur is the Executive Chairman and Secretary of the Company and has been a member of the Board since September 2014. Mr. Mazur also
serves as the Secretary of our majority-owned subsidiary, NoveCite, Inc., and provides other guidance to NoveCite. Mr. Mazur is the co-founder
and Vice Chairman of Akrimax Pharmaceuticals, LLC (&ldquo;Akrimax&rdquo;), a privately held pharmaceutical company specializing in producing
cardiovascular and general pharmaceutical products. Akrimax was founded in September 2008 and has successfully launched prescription
drugs while acquiring drugs from major pharmaceutical companies. From January 2005 to May 2012, Mr. Mazur co-founded and served as the
Chief Operating Officer of Triax Pharmaceuticals LLC (&ldquo;Triax&rdquo;), a specialty pharmaceutical company producing prescription
dermatological drugs. Prior to joining Triax, he was the founder and, from 1995 to 2005, Chief Executive Officer of Genesis Pharmaceutical,
Inc. (&ldquo;Genesis&rdquo;), a dermatological products company that marketed its products through dermatologists&rsquo; offices as well
as co-promoting products for major pharmaceutical companies. In 2003, Mr. Mazur successfully sold Genesis to Pierre Fabre, a leading
pharmaceutical company. Mr. Mazur has extensive sales, marketing and business development experience from his tenures at Medicis Pharmaceutical
Corporation as executive vice president, ICN Pharmaceuticals, Inc. as vice president, sales &amp; marketing, Knoll Pharma (a division
of BASF), and Cooper Laboratories, Inc. Mr. Mazur is a member of the Board of Trustees of Manor College, is a recipient of the Ellis
Island Medal of Honor and was previously the chairman of the board of directors of LMB, the Company&rsquo;s wholly-owned subsidiary.
Mr. Mazur received both his B.A. and M.B.A. from Temple University and has served in the U.S. Marine Corps Reserves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Mr. Mazur is qualified to serve as a director because of his entrepreneurial experience and marketing knowledge in
the pharmaceutical industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Suren
Dutia</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren
Dutia has been a member of the Board since October 2015. Mr. Dutia has served as Senior Fellow of the Ewing Mario Kauffman Foundation
since March 2011 and as Senior Fellow of Skandalaris Center for Entrepreneurial Studies at Washington University, St. Louis since 2013.
He has served as a member of the advisory board of Center for Digital Transformation, University of California, Irvine since May 2012
and as chairman of the board of directors of AccelPath, LLC since October 2009. From February 2006 to May 2010, Mr. Dutia served as the
Chief Executive Officer of TiE Global, a non-profit organization involved in globally fostering entrepreneurship. From February 2011
to May 2013, Mr. Dutia served as a director of LifeProof Cases and from July 2000 to December 2011, he served as a director of Anvita
Health. From 1989 to 1998, Mr. Dutia served as the Chief Executive Officer and chairman of the board of directors of Xscribe Corporation.
Prior to his positions with Xscribe Corporation, Mr. Dutia held several positions with Dynatech Corporation, and, in addition, he was
the president of a medical instruments company. Previously, Mr. Dutia worked for the U.S. Department of Education. Mr. Dutia received
his B.S. and M.S. degrees in chemical engineering and B.A. in political science from Washington University, St. Louis. In addition, he
obtained an M.B.A. from University of Dallas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Mr. Dutia is qualified to serve as a director because of his financial management background, his involvement with
start-up companies and his management skills.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Carol
Webb</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carol
Webb has served as a director of LMB since March 17, 2014 and, upon LMB&rsquo;s acquisition by the Company in March 2016, a director
of the Company. From 2000 to 2005, she served as Company Group Chairman of Johnson &amp; Johnson. From 1987 to 2000, she served in various
capacities at Ortho Biotech, including President, Vice President, Executive Director, Product Management and Senior Product Director.
From 1972 to 1983, Ms. Webb worked in various positions at Roche Laboratories, including Sales Representative, Sales Trainer, Product
Manager and Manager of Public Policy. Ms. Webb received her B.S. in Biology from Bowling Green State University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Ms. Webb is qualified to serve as a director because she brings over 40 years of pharmaceutical sales, marketing
and business development experience to our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dr.
William Kane</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
William (Terry) Kane served as a director of LMB from March 28, 2014 until LMB&rsquo;s acquisition by the Company in March 2016. Since
the acquisition of LMB by the Company, Dr. Kane has served as a director of the Company. He has served as a Clinical Professor at Duke
University Medical Center since 2003. From 2008 to 2012, Dr. Kane was on the Board of the First Flight Venture Center (&ldquo;FFVC&rdquo;)
in Research Triangle Park, North Carolina and chaired the FFVC Board from 2012 to 2016. From 2006 to 2009, he served as the Chief Executive
Officer of RadarFind Corporation, and from 2002 to 2003, he served as the Interim Chief Medical Officer of Mercy Fitzgerald Hospital.
From 1996 until 2002, Dr. Kane served as the President and Chief Executive Officer of InteCardia, Inc., and from 1995 until 1996, he
was a healthcare consultant. From 1993 to 1995, Dr. Kane served in various capacities at Sharp Healthcare including Executive Vice President,
Operations and Executive Vice President, Community Care. From 1992 to 1993, he was the Senior Vice President, Medical Affairs at Independence
Blue Cross, and from 1990 to 1992, he served in various capacities at CentraState Medical Center including President, Chief Executive
Officer, Executive Vice President and Chief Operating Officer. From 1989 to 1990, Dr. Kane was with Cain Brothers, Shattuck &amp; Co.,
and from 1988 to 1989, he was the Senior Vice President, Health Services Division of American International Healthcare (formerly JBI).
From 1986 to 1987, Dr. Kane was the Executive Vice President and Corporate Medical Director of CIGNA Healthplan, Inc., and from 1984
to 1986, he was at U.S. Healthcare, Inc. and served in various capacities including Senior Vice President Medical Delivery, President
and Senior Medical Director. Dr. Kane is currently the chair of the board of directors of Research Triangle Park and was a past member
of the board of directors of Pisacano Leadership Foundation and Make-A-Wish Foundation. In addition, he previously served on the Management
Advisory Committee of Cornucopia House Cancer Support Center. Dr. Kane received his B.S. in Biology from the University of Scranton and
his M.D. with Honors from the Temple University School of Medicine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Dr. Kane is qualified to serve as a director because of his extensive experience and leadership in the healthcare
industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Howard
Safir</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
Safir served as a director of LMB from April 2014 until LMB&rsquo;s acquisition by the Company in March 2016. Since the acquisition of
LMB by the Company, Mr. Safir has served as a director of the Company. He has served as Chairman and Chief Executive Officer of VRI Technologies
LLC, a security consulting and law enforcement integrator since July 2010. From 2001 until 2010, Mr. Safir served as the Chairman and
Chief Executive Officer of Safir Rosetti, a provider of security and investigation services and a wholly-owned subsidiary of Global Options
Group Inc. Mr. Safir served as the Vice Chairman of Global Options Group Inc. from its 2005 acquisition of Safir Rosetti until 2010.
He served as Chief Executive Officer of Bode Technology, also a wholly-owned subsidiary of Global Options Group Inc., from 2007 to 2010.
Mr. Safir served as a director of Implant Sciences Corporation (OTCQB: IMSC), an explosives device detection company, until its acquisition
by L3 Technologies. Mr. Safir currently serves as a director of LexisNexis Special Services, Inc., a leading provider of information
and technology solutions to governments, as well as Verint Systems Inc (NASDAQ: VRNT), a provider of software and hardware products for
customer engagement management, security, surveillance, and business intelligence. During his career, Mr. Safir served as the 39<SUP>th
</SUP>Police Commissioner of the City of New York, as Associate Director for Operations, U.S. Marshals Service and as Assistant Director
of the Drug Enforcement Administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Mr. Safir is qualified to serve as a director because of his background of serving on public company boards and his
business experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dr.
Eugene Holuka</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Eugene Holuka has served as a director of the Company since June 2016. Dr. Holuka is an internist and has practiced in critical care
medicine for almost 30 years. He is presently an attending physician at the Staten Island University Hospital where he has practiced
since 1991. Dr. Holuka has also served as an Adjunct Clinical Assistant Professor at the Touro College of Osteopathic Medicine since
2011. From April 2014 until the acquisition of LMB by the Company in March 2016, he was a member of the LMB Scientific Advisory Board.
Dr. Holuka received the Ellis Island Medal of Honor in 2000 and has served on the NECO Committee Board since 2005. He was an Executive
Committee Member on the Forum&rsquo;s Children Foundation from 2000 until 2008.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that Dr. Holuka is qualified to serve as a director because of his extensive experience in the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
there is a quorum for the meeting, pursuant to the terms of our Bylaws, the election of each director requires the affirmative vote of
a majority of the votes represented at the Annual Meeting in person or by proxy and entitled to vote on this Proposal No. 1. Broker non-votes,
if any, are not entitled to vote, and therefore will have no effect on the election of directors. Withheld votes, if any, are entitled
to vote, and therefore will have the same effect as a vote against the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board unanimously recommends that stockholders vote <B>FOR</B> the election of the seven nominees for election to the Board for a one-year
term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NON-BINDING
ADVISORY VOTE ON EXECUTIVE COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required under Section 14A of the Securities Exchange Act of 1934, as amend, or the Exchange Act, and the Dodd-Frank Wall Street Reform
and Consumer Protection Act of 2010, or Dodd-Frank Act, the Board of Directors is submitting a &ldquo;say on pay&rdquo; proposal for
stockholder consideration. While the vote on executive compensation is nonbinding and solely advisory in nature, the Board and the Compensation
Committee value the opinion of our stockholders and will review and consider the voting results. We currently intend to hold future advisory
votes on executive compensation every three years, and the next say on pay vote is expected to occur at the annual meeting of our stockholders
in 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers are compensated based on performance, and in a manner consistent with our strategy, competitive practice, sound corporate
governance principles, and our company&rsquo;s and our stockholders&rsquo; interests. We believe our compensation program is strongly
aligned with the long-term interests of our company and our stockholders. Compensation of our executive officers is designed to enable
us to attract and retain talented and experienced senior executives to lead our company successfully in a competitive environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation of the Named Executive Officers is described on pages 20-28 of this proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are asking stockholders to vote on the following resolution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>RESOLVED</B>,
that the stockholders of Citius Pharmaceuticals, Inc. approve, <FONT STYLE="background-color: white">on an advisory basis, the compensation
paid to its Named Executive Officers, as disclosed pursuant to the compensation disclosure rules of the SEC, including the compensation
tables and narrative discussion as disclosed in this proxy statement.&rdquo;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
indicated above, the stockholder vote on this resolution will not be binding on our company or the Board of Directors and will not be
construed as overruling or determining any decision by us or by the Board. The vote will not be construed to create or imply any change
to our fiduciary duties or those of the Board, or to create or imply any additional fiduciary duties for our company or the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
there is a quorum for the meeting, the approval on a non-binding advisory basis of our executive compensation requires the affirmative
vote of the holders of a majority of the shares of our common stock present in person or represented by proxy at the Annual Meeting in
person or by proxy and entitled to vote on this Proposal No. 2. Broker non-votes, if any, are not entitled to vote, and therefore will
have no effect on this Proposal 2. Abstentions, if any, are entitled to vote, and therefore will have the same effect as a vote against
this Proposal 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends that stockholders vote FOR the approval, on a non-binding advisory basis, of our executive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADVISORY
VOTE ON FREQUENCY OF SAY-ON-PAY VOTES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section&nbsp;14A of the Exchange Act and the Dodd-Frank Act, we are required to seek a nonbinding advisory stockholder vote regarding
the frequency of submission to stockholders of an&nbsp;advisory vote on executive compensation such as Proposal 2. The Dodd-Frank Act
specifies that at least once every six years we give our stockholders the opportunity to vote on the preferred frequency of future votes
on our executive compensation either annually, every two years or every three years. We plan to present this proposal to our stockholders
at least once every six years. Accordingly, the next vote on the frequency of voting on our executive compensation is expected to occur
at the annual meeting of our stockholders in 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is providing stockholders the option of selecting a frequency of one, two or three years, or abstaining. At the Company&rsquo;s
2016 Annual Meeting, the stockholders approved a frequency of every three years. For the reasons described below, the Company recommends
that the stockholders again select a frequency of three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company's executive compensation program is designed to support long-term value creation, we believe a vote every three years will
allow for the highest level of accountability and direct communication between the Company and its stockholders. The Company, therefore,
recommends that our stockholders select &ldquo;Every Three Years&rdquo; when voting on the frequency of advisory votes on executive compensation.
Although the advisory vote is non-binding, the Board of Directors&nbsp;will review the results of the vote and take them into account
in making a determination concerning the frequency of future advisory votes on executive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
option of one year, two years or three years that receives the highest number of votes cast by stockholders will be the frequency of
the advisory vote on executive compensation that has been selected by stockholders. However, because this vote is advisory and not binding
on the Board of Directors or the Company, the Board of Directors may decide that it is in the best interests of the stockholders and
the Company to hold an advisory vote on executive compensation more or less frequently than the option approved by the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Provided there is a quorum for the meeting, the
approval on a non-binding advisory basis of your preference for the frequency of holding future advisory votes on our executive compensation
requires the affirmative vote of the holders of a majority of the shares of our common stock present in person or represented by proxy
at the Annual Meeting in person or by proxy and entitled to vote on this Proposal 3. Broker non-votes, if any, are not entitled to vote,
and therefore will have no effect on this Proposal 3. Abstentions, if any, are entitled to vote, and therefore will have the same effect
as a vote against this Proposal 3. The option of one year, two years or three years that receives the highest number of votes cast by
stockholders will be the frequency of the advisory note on executive compensation that has been selected by stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board recommends that stockholders vote FOR the option of three years as your preference for the frequency of holding future advisory
votes on our executive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RATIFICATION
OF THE SELECTION OF WOLF &amp; COMPANY, P.C.,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AN
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE AUDITOR OF THE COMPANY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE FISCAL YEAR ENDING SEPTEMBER 30, 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s stockholders are being asked to ratify the Board of Directors&rsquo; selection of Wolf &amp; Company, P.C. (&ldquo;Wolf&rdquo;),
an independent registered public accounting firm, as the auditor of the Company for the fiscal year ending September 30, 2022. While
the Audit Committee is solely responsible for the appointment, compensation, retention and oversight of the independent registered public
accounting firm, the Committee and the Board are requesting that the stockholders ratify this appointment. If the stockholders ratify
this appointment, the Audit Committee, in its discretion, may appoint a different independent registered public accounting firm at any
time during the year if it believes that doing so would be in the best interests of the Company and our stockholders. If the stockholders
do not ratify this appointment, the Audit Committee may reconsider, but might not change, its appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of Wolf is not expected to be present in person but will attend telephonically the Annual Meeting and will have an opportunity
to make a statement if he or she desires to do so. It is also expected that such representative will be available to respond to appropriate
questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
there is a quorum for the meeting, ratification of the appointment of Wolf as our auditor for the fiscal year ending September 30, 2022
requires the affirmative vote of a majority of the votes represented at the Annual Meeting in person or by proxy and entitled to vote
on this Proposal No. 4. Broker non-votes and abstentions, if any, are entitled to vote, and therefore will have the same effect as a
vote against this Proposal No. 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board unanimously recommends that stockholders vote <B>FOR</B> the ratification of the Board of Directors&rsquo; appointment of Wolf
&amp; Company, P.C., an independent registered public accounting firm, as the auditor of the Company for fiscal year 2022.</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATE
GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Regarding the Board and its Committees</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Composition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board currently consists of seven members. Each director elected at this meeting will serve until the Company&rsquo;s 2023 Annual Meeting
of Stockholders or until a successor is duly elected and qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is responsible for the selection of the Chairman of the Board, the Chief Executive Officer and the Lead Independent
Director. Our Board does not have a policy on whether or not the roles of Chief Executive Officer and Chairman should be separate and,
if they are to be separate, whether the Chairman should be selected from the non-employee directors or be an employee. Our Board of Directors
appointed Myron Holubiak as our Chief Executive Officer and Leonard Mazur as the Executive Chairman of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among our executive officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selection
of Nominees for our Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Governance Committee of our board of directors is responsible for establishing the criteria for recommending which directors
should stand for re-election to the Board and the selection of new directors to serve on the Board. In addition, the Committee is responsible
for establishing the procedures for our stockholders to nominate candidates to the Board. Board candidates are typically identified by
existing directors or members of management. The committee considers the needs for the Board of Directors as a whole when identifying
and evaluating nominees and, among other things, considers diversity in background, age, experience, qualifications, attributes and skills
in identifying nominees, although it does not have a formal policy regarding the consideration of diversity. Each director nominee is
recommended by the Nominating and Governance Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Company&rsquo;s Bylaws, our stockholders may select individuals to be nominated for election to the Board of Directors by providing
written notice to the Company no more than 90 and not less than 60 days before the meeting. Such notice must set forth the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
name and address, as they appear on the Company&rsquo;s books, of the stockholder who intends to make the nomination and the name and
residence address of the person or persons to be nominated;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            class and number of shares of the Company that are beneficially owned by the stockholder;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            representation that the stockholder is a holder of record of stock of the Company entitled
                                            to vote at such meeting and intends to appear in person or by proxy at the meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            description of all arrangements or understandings between the stockholder and each nominee
                                            and any other person or persons pursuant to which the nomination was made;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            other information regarding each nominee proposed by such stockholder as would be required
                                            to be disclosed in solicitations of proxies for election of directors, pursuant to Regulation
                                            14A under the Exchange Act, including any information that would be required to be included
                                            in a proxy statement filed pursuant to Regulation 14A had the nominee been nominated by the
                                            board of directors; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            written consent of each nominee to be named in a proxy statement and to serve as director
                                            of the Company if so elected.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee will evaluate a nominee recommended by a stockholder in the same manner in which the Committee evaluates
nominees recommended by other persons as well as its own nominee recommendations. No stockholder has nominated anyone for election as
a director at this Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
review of all relevant transactions or relationships between each nominee for director, or any of his or her family members, and the
Company, its senior management and Wolf, its independent registered public accounting firm, the Board of Directors has determined that
all of the Company&rsquo;s directors and the Company&rsquo;s nominees for director are independent within the meaning of the applicable
NASDAQ listing standards, except Leonard Mazur, the Executive Chairman and Secretary of the Company, and Myron Holubiak, the Chief Executive
Officer and President of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
Committees</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a Nominating and Governance Committee, Audit and Risk Committee, and Compensation Committee. The Board has determined that
each of the members of the Nominating and Governance, Audit and Risk and Compensation Committees is independent. The adopted written
charters for each of these committees are available under the <I>Investors Relations </I>section of our website at <I>www.citiuspharma.com</I>.
Each committee is required to perform an annual evaluation of its charter, and each committee may engage outside independent advisors
as the committee deems appropriate. A brief description of the responsibilities of the Nominating and Governance, Audit and Risk and
the Compensation Committees follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
and Risk Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit and Risk Committee consists of Messrs. Dutia (Chair) and Safir and Dr. Kane. Each of Messrs. Dutia and Safir and Dr. Kane satisfy
the independence requirements of Rule 5605(a)(2) of the NASDAQ Stock Market listing rules and SEC Rule 10A-3. Our Audit and Risk Committee
is responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
                                            terminating, compensating, and overseeing the work of any accounting firm engaged to prepare
                                            or issue an audit report or other audit, review or attestation services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving, in advance, all audit and non-audit services to be performed by the independent
                                            auditor, taking into consideration whether the independent auditor&rsquo;s provision of non-audit
                                            services to us is compatible with maintaining the independent auditor&rsquo;s independence;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing the adequacy and effectiveness of our accounting and financial reporting processes
                                            and controls and the audits of our financial statements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            and overseeing procedures for the receipt, retention, and treatment of complaints received
                                            by us regarding accounting, internal accounting controls or auditing matters, including procedures
                                            for the confidential, anonymous submission by our employees regarding questionable accounting
                                            or auditing matters;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
                                            and evaluating the independent auditor&rsquo;s qualifications, performance, and independence
                                            on an ongoing basis; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving related-party transactions for potential conflict of interest situations on
                                            an ongoing basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has affirmatively determined that Mr. Dutia is designated as the &ldquo;audit committee financial expert.&rdquo; The
designation does not impose on Mr. Dutia any duties, obligations or liabilities that are greater than those generally imposed on members
of our audit committee and our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee consists of Mr. Safir (Chair), Ms. Webb and Dr. Holuka. Our Compensation Committee is responsible for, among other
things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving the compensation, employment agreements and severance arrangements, and other
                                            benefits of all of our executive officers and key employees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving, on an annual basis, the corporate goals and objectives relevant to the compensation
                                            of the executive officers, and evaluating their performance in light thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and making recommendations, on an annual basis, to the Board with respect to director compensation;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            any analysis or report on executive compensation required to be included in the annual proxy
                                            statement and periodic reports pursuant to applicable federal securities rules and regulations,
                                            and recommending the inclusion of such analysis or report in our proxy statement and period
                                            reports.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to its written charter, our Compensation Committee has the authority to engage the services of outside advisors as it deems appropriate
to assist it in the evaluation of the compensation of our directors, principal executive officer or other executive and non-executive
officers, and in the fulfillment of its other duties. Additionally, our Compensation Committee has the authority to review and approve
the compensation of our other officers and employees and may delegate its authority to review and approve the compensation of other non-executive
officer employees to specified executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
and Governance Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Governance Committee consists of Dr. Kane (Chair), Dr. Holuka and Ms. Webb. It is responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
                                            and screening candidates for our Board, and recommending nominees for election as directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            procedures to exercise oversight of the evaluation of the Board and management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            the structure of the Board&rsquo;s committees and recommending to the board for its approval
                                            directors to serve as members of each committee, and where appropriate, making recommendations
                                            regarding the removal of any member of any committee;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing
                                            and reviewing our code of conduct, evaluating management&rsquo;s communication of the importance
                                            of our code of conduct, and monitoring compliance with our code of conduct; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">generally
                                            advising our Board on corporate governance and related matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Regarding Meetings of the Board and Committees</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
business of our Company is under the general oversight of our Board as provided by the laws of Nevada and our bylaws. During the year
ended September 30, 2021, our Board held seven meetings, our Audit and Risk Committee held three meetings, our Compensation Committee
held one meeting and our Nominating and Governance Committee held one meeting. In fiscal 2021, each director nominee attended at least
75% of the Board meetings and the meetings of the committee on which he or she served since being appointed to the Board and respective
committees. Our Board, our Compensation Committee and our Nominating and Governance Committee also took certain actions by unanimous
written consent during fiscal 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a formal policy regarding attendance of Board members at annual meetings, but we encourage them to do so. Directors Myron
Holubiak and Leonard Mazur attended the 2021 Annual Meeting in person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Code
of Ethics</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a code of ethics relating to the conduct of our business by all of our employees, officers and directors. We have also adopted
a corporate communications policy for our employees and directors establishing guidelines for the disclosure of information related to
the Company to the investing public, market analysts, brokers, dealers, investment advisors, the media, and any persons who are not our
employees or directors. Additionally, we have adopted an insider trading policy to establish guidelines for our employees, officers,
directors, and consultants regarding transactions in our securities and the disclosure of material nonpublic information related to our
Company. Each of these policies is posted under the <I>Investors Relations</I> section of our website at www.citiuspharma.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anti-Hedging
and Anti-Pledging Policy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has not adopted an anti-hedging or anti-pledging policy.&nbsp;However, our Insider Trading Policy strongly discourages
our directors, officers and employees from engaging in any hedging activity in our securities or pledging any of our securities as collateral
for loans or margin accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risk
Oversight</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
management is responsible for managing the day-to-day issues faced by the Company, our Board of Directors has an active role in the oversight
of the Company&rsquo;s risk management efforts. The Board of Directors receives and reviews periodic reports from management, auditors,
legal counsel, and others, as considered appropriate regarding the Company&rsquo;s assessment of risks. The Board of Directors focuses
on the most significant risks facing the Company and the Company&rsquo;s general risk management strategy, and also ensures that risks
undertaken by the Company are consistent with the Board&rsquo;s appetite for risk. We believe this division of responsibilities is the
most effective approach for addressing the risks facing the Company and that our Board leadership structure supports this approach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to promote open discussion among non-employee directors, our Board of Directors has a policy of regularly conducting executive
sessions of non-employee directors at scheduled meetings and at such other times requested by any non-employee director. In June 2016,
Howard Safir was selected by the Board to serve as lead independent director until a successor is elected and qualified. As lead independent
director, Mr. Safir provides valuable leadership to the independent directors, presides over meetings and sessions of the independent
directors, and advises the Board on matters where there may be an actual or perceived conflict of interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholder
Proposals</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws establish procedures for bringing business before any annual meeting or special meeting of stockholders and stockholder director
nominations. A stockholder entitled to vote in the election of directors may submit a stockholder proposal or nominate one or more persons
for election as directors at a meeting only if written notice of such stockholder&rsquo;s intent to make such proposal or nomination
has been delivered to our Corporate Secretary at our principal executive offices not less than 60 days nor more than 90 days prior to
the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder&rsquo;s notice must set forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            brief description of the business desired to be brought before the meeting and the reasons
                                            for conducting such business at the meeting and, if such business includes a proposal to
                                            amend our bylaws, the language of the proposed amendment;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            name and address, as they appear on the Company&rsquo;s books, of the stockholder proposing
                                            such business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            class and number of shares that are beneficially owned by such stockholder;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            representation that the stockholder is a holder of record of stock entitled to vote at such
                                            meeting and intends to appear in person or by proxy at the meeting to propose such business;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            material interest of the stockholder in such business.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder must also comply with all applicable laws, rules and regulations, including the Securities Act of 1933, as amended, and rules
promulgated thereunder governing proxies and stockholder proposals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the absence of such notice to the Company meeting the above requirements, a stockholder will not be entitled to present any business
at any meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;<I>Selection of Nominees for our Board of Directors</I>&rdquo; for procedures for proxy access for stockholder director nominations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE
OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
names of our executive officers and their ages, positions, and biographies as of November 30, 2021 are set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0; width: 1%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0; width: 1%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 61%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Myron
    Holubiak</B></FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leonard
    Mazur</B></FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and Secretary</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jaime
    Bartushak</B></FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Myron
    S. Czuczman, M. D.</B></FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer and Executive Vice President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2016, Mr. Mazur was appointed as Executive Chairman and Secretary of the Company and Mr. Holubiak was appointed President and Chief
Executive Officer of the Company. On November 27, 2017, Mr. Bartushak was appointed as Chief Financial Officer of the Company. On July
14, 2020, Dr. Czuczman was appointed Chief Medical Officer and Executive Vice President of the Company. The biographies for Myron Holubiak
and Leonard Mazur are contained in the information disclosures relating to the Company&rsquo;s nominees for director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Jaime
Bartushak</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 1, 2014 until November 2017, Mr. Bartushak served as Chief Financial Officer of Leonard-Meron Biosciences, Inc. (&ldquo;LMB&rdquo;),
a wholly-owned subsidiary of the Company. Mr. Bartushak is an experienced finance professional for early stage pharmaceutical companies,
and has over 20 years of corporate finance, business development, restructuring, and strategic planning experience. Mr. Bartushak was
one of the founders of LMB in 2014 and was instrumental in its startup as well as in obtaining initial investment capital. In 2014, prior
to his work at LMB, Mr. Bartushak helped lead the sale of PreCision Dermatology, Inc. to Valeant Pharmaceuticals International, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Myron
S. Czuczman, M.D.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Czuczman joined Citius in July 2020. Prior to his employment with us, Dr. Czuczman was Vice President, Global Clinical Research and Development,
Therapeutic Area Head of Lymphoma/CLL at Celgene Corporation, a position he held for five years. Prior to working in the pharmaceutical
industry, Dr. Czuczman practiced medicine for over two decades at Roswell Park Cancer Institute in Buffalo, New York. Dr. Czuczman received
his M.D. degree from the Pennsylvania State University College of Medicine after graduating magna cum laude in Biochemistry from the
University of Pittsburgh.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table shows the amount of our common
stock beneficially owned as of November 30, 2021 by (i) each person or group as those terms are used in Section 13(d)(3) of the Exchange
Act believed by us to beneficially own more than 5% of our common stock, (ii) each of our directors, (iii) each of our named executive
officers, and (iv) all of our directors and named executive officers as a group. Except as otherwise noted, each person named in the table
has sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Name of Beneficial Owner (1)</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Number of Shares of Common Stock Beneficially Owned<BR>
 (2)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Percentage of Shares of Common Stock Beneficially Owned <BR>
(3)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic">Executive Officers and Directors</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Leonard Mazur (4)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18,092,136</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11.76</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Myron Holubiak (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,864,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.61</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jaime Bartushak (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">311,953</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Myron S. Czuczman, M.D. (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Suren Dutia (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dr. William Kane (9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Howard Safir (9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Carol Webb (9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Eugene Holuka (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,749</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left">All executive officers and directors as a group (9 people)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">23,228,975</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">14.80</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 1%.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1) </FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The address for our officers and directors is c/o of the Company, 11 Commerce Drive, 1st Floor, Cranford, New Jersey 07016.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2) </FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of common stock subject to options or warrants currently exercisable or convertible, or exercisable or convertible within 60 days of November 30, 2021 are deemed outstanding for computing the percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other person.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3) </FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Percentage based on 146,029,630 shares of common stock issued and outstanding at November 30, 2021.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(4)</TD><TD>Consists of (i) 10,255,343 shares of common stock, (ii) 593,333 shares of common stock issuable upon exercise of options and (iii)
warrants to purchase an aggregate of 7,243,460 shares of common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(5)</TD><TD>Consists of (i) 1,992,243 shares of common stock, (ii) 400,000 shares of common stock issuable upon exercise of options and (iii)
warrants to purchase an aggregate of 1,472,361 shares of common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(6)</TD><TD>Consists of (i) 60,353 shares of common stock and (ii) 251,600 shares of common stock issuable upon exercise of options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(7)</TD><TD>Consists of 166,650 shares of common stock issuable upon exercise and options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(8)</TD><TD>Consists of 161,667 shares of common stock issuable upon exercise of options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(9)</TD><TD>Consists of 160,405 shares of common stock issuable upon exercise of options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(10)</TD><TD>Consists of 150,749 shares of common stock issuable upon exercise of options.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Compensation for the fiscal year ended September 30, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective July 1, 2021, the Board approved a compensation plan for
non-employee directors after receiving input from Frederic W. Cook &amp; Co. (&ldquo;FW Cook&rdquo;), an independent compensation consultant.
Non-employee directors each receive an annual retainer of $40,000, but no compensation for meetings attended. In addition: (i) the Lead
Independent Director receives an additional annual retainer of $15,000, (ii) the Audit and Risk Committee chairman receives an additional
annual retainer of $17,000, the Compensation Committee chairman receives an additional annual retainer of $12,000, and the Nominating
and Corporate Governance Committee chairman receives an additional annual retainer of $10,000, and (iii) Audit Committee members receive
an annual retainer of $8,500, Compensation Committee members receive an annual retainer of $6,000, and Nominating and Governance Committee
members receive an annual retainer of $5,000. Prior to July 1, 2021, non-employee directors each received an annual retainer of $32,500,
but no compensation for meetings attended. In addition: (i) the Lead Independent Director received an additional annual retainer of $10,000,
(ii) the Audit and Risk Committee chairman received an additional annual retainer of $15,000, the Compensation Committee chairman received
an additional annual retainer of $10,000, and the Nominating and Corporate Governance Committee chairman received an additional annual
retainer of $7,500, and (iii) Audit Committee members received an annual retainer of $7,500, Compensation Committee members received an
annual retainer of $5,000, and Nominating and Governance Committee members received an annual retainer of $3,750. Director compensation
for the year ended September 30, 2021, was accordingly prorated for the two compensation plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Director compensation for the year ended September
30, 2021 was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fees <BR>
Earned or<BR>
 Paid in<BR>
 Cash (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock<BR>
Awards</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<BR>
Awards (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other<BR>
Compensation</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Suren Dutia (2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">49,875</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">79,696</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">129,571</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Carol Webb (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">43,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">79,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">123,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. William Kane (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">79,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">129,946</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Howard Safir (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">63,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">79,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">143,571</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Eugene Holuka (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">43,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">79,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">123,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The dollar amount set forth
    in the table represents the dollar amount recognized for financial statement reporting purposes with respect to the fiscal year on
    an accrual basis for fees earned and in accordance with <I>FASB ASC Topic 718</I> for option awards.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At September 30, 2021, the non-employee directors held the following options to purchase shares of common stock: Mr. Dutia, 176,667; Ms. Webb, 175,405; Dr. Kane, 175,405; Mr. Safir, 175,405; and Dr. Holuka, 165,749.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE COMPENSATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Executive Compensation Objectives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We seek to achieve the following broad goals in
our executive compensation programs and decisions regarding individual compensation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Attract and retain executives critical
to our overall success.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Reward executives for contributions to achieving strategic goals that enhance stockholder value.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Foster and maintain a company culture of ownership, creativity and innovation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Motivate our executive officers to achieve critical long- and short-term development, product and financial milestones set by the Board in consultation with management.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General Compensation Process</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compensation Committee is responsible for determining
the elements and levels of compensation for our executive officers who are named in the Summary Compensation Table and whom we refer to
as Named Executive Officers in this proxy statement. In doing so, the Compensation Committee reviews our corporate performance against
financial and corporate achievement measures, assesses individual performance and evaluates recommendations of the Chief Executive Officer
regarding compensation for other Named Executive Officers. Deliberations of the Compensation Committee may occur within a meeting of the
full Board of Directors at which all members of the Compensation Committee are in attendance and the Board of Directors may take action
in such meetings upon the advice of the Compensation Committee chair and/or its members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To assist in its deliberations regarding executive
compensation, in fiscal 2018 and again in fiscal 2021 the Compensation Committee directly engaged FW Cook as its compensation consultant.
FW Cook does not undertake any work for us other than its services for the Compensation Committee. The Compensation Committee has determined
that FW Cook is independent and that its services do not raise any conflict of interest with us or any of our executive officers or directors.
In carrying out its work for the Compensation Committee, FW Cook interacts from time to time directly with our management, as it determines
appropriate, regarding its work product prior to presentation to the Compensation Committee in order to confirm alignment with our business
strategy and obtain data or information necessary for its work.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">FW Cook reviewed and discussed with the Compensation
Committee competitive market compensation data for consideration when determining different levels and mix of compensation. The Compensation
Committee reviewed publicly available compensation information of executive officers as well as aggregate share usage and dilution of
a peer group of companies within the biotechnology and pharmaceuticals industries. These companies were selected by the Compensation Committee
with FW Cook&rsquo;s assistance and were similar to the Company in terms of size, business model and state of development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The peer group consisted of the following companies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="float: left; width: 48%">

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Arbutus Biopharma Corporation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cidara Therapeutics, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">ContraFect Corporation</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">CorMedix Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cue Biopharma, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Genocea Biosciences, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Heat Biologics, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Hepion Pharmaceuticals, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">HOOKIPA Pharma Inc.</FONT></TD></TR></TABLE>

</DIV>
<DIV STYLE="float: right; width: 48%">


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Matinas BioPharma Holdings, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Novan, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">OpGen, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Oragenics, Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Regulus Therapeutics Inc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">SCYNEXIS, Inc.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Spero Therapeutics, Inc.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">XBiotech Inc.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>
<DIV STYLE="clear: both"></DIV>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The peer company compensation data provided by
FW Cook is used by the Compensation Committee as a general reference point in its compensation review. The Compensation Committee does
not set compensation levels at any specific level or percentile against this compensation data (i.e., the Compensation Committee does
not &ldquo;benchmark&rdquo; our executive compensation levels). The peer group data is only one point of information taken into account
by the Compensation Committee in making compensation decisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">After review and approval by the Compensation Committee
of FW Cook&rsquo;s recommendations, effective August 1, 2021, the Board adopted the Committee&rsquo;s recommendation for stock option
grant guidelines as well as increases in executive compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Components of Compensation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The key components of our executive compensation
package are cash compensation (salary and annual bonuses), long-term equity incentive awards and change in control provisions in employment
agreements. These components are administered with the goal of providing total compensation that recognizes meaningful differences in
individual performance, is competitive, varies the opportunity based on individual and corporate performance, and is valued by our Named
Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Base Salary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is the Compensation Committee&rsquo;s objective
to set a competitive rate of annual base salary for each Named Executive Officer. The Compensation Committee believes competitive base
salaries are necessary to attract and retain top quality executives, since it is common practice for public companies to provide their
named executive officers with a guaranteed annual component of compensation that is not subject to performance risk. The Compensation
Committee, on its own or with outside consultants, namely FW Cook, may establish salary ranges for our Named Executive Officers, with
minimum to maximum opportunities that cover the normal range of market variability. The actual base salary for each Named Executive Officer
is then derived from those salary ranges based on his responsibility, tenure and past performance and market comparability. Annual base
salaries for the Named Executive Officers are reviewed and approved by the Compensation Committee. Changes in base salary are based on
the scope of an individual&rsquo;s current job responsibilities, individual performance in the previous performance year, target pay position
relative to the peer group, and our salary budget guidelines. The Compensation Committee reviews established goals and objectives, and
determines an individual&rsquo;s achievement of those goals and objectives and considers the recommendations provided by the Chief Executive
Officer to assist it in determining appropriate salaries for the Named Executive Officers other than the Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The base salary information for our Named Executive
Officers for fiscal 2020 and 2021 is set forth in the Summary Compensation Table below. We entered into an employment agreement with each
of Leonard Mazur, our Executive Board Chairman, Myron Holubiak, our Chief Executive Officer, Jaime Bartushak, our Chief Financial Officer,
and Myron S. Czuczman, M.D., our Chief Medical Officer and Executive Vice President, in October 2017, March 2016, November 2017 and July
2020, respectively. These agreements provide for a salary for each Named Executive Officer and are described under the caption &ldquo;<I>Employment
Agreements&rdquo; </I>below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Annual Bonuses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As part of their compensation package, and pursuant
to the terms of their employment agreements, our Named Executive Officers generally have the opportunity to earn annual non-equity incentive
bonuses. Annual non-equity bonuses are designed to reward superior executive performance while reinforcing our short-term strategic operating
goals. Annual bonus targets as a percentage of salary increase with executive rank so that for the more senior executives, a greater proportion
of their total cash compensation is contingent upon annual performance. Each year the Compensation Committee establishes corporate goals
for our Company in consultation with our Chief Executive Officer, with weights assigned to each goal, depending on the extent to which
each Named Executive Officer is responsible for each specific goal. The extent to which these goals are met will determine the amount
of the non-equity bonus that each Named Executive Officer receives. Pursuant to the terms of their employment agreements, the target award
for each Named Executive Officer is based on a percentage of his base salary, and subject to the applicable terms in his individual employment
agreement. Pursuant to their respective employment agreements, Mr. Mazur, Mr. Holubiak, Mr. Bartushak and Dr. Czuczman are each eligible
for an annual bonus, which may equal up to 50%, 50%, 40% and 35%, respectively, of his base salary then in effect, as determined by our
Board or the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For fiscal 2021, the annual non-equity incentive
bonuses for our executive officers were based on the achievement of company goals during fiscal 2021, which were established in November
2020 and related to clinical studies for Mino-Lok and Halo-Lido, work on progressing each of Mino-Wrap and NoveCite towards an IND, raising
capital and increasing our market capitalization. These specific goals were evaluated and selected because they were considered key drivers
for creating and growing Company value. For fiscal 2021, Mr. Mazur, Mr. Holubiak, Mr. Bartushak and Dr. Czuczman were potentially entitled
to cash bonuses of up to $200,000, $225,000, $130,000 and $140,000, respectively. Based on the achievement of the revised corporate goals
for fiscal 2021, of which most were met and, given their weighting, resulted in overachievement of the goals, the Board approved the payment
to Mr. Mazur, Mr. Holubiak, Mr. Bartushak and Dr. Czuczman of a cash bonus equal to an average of approximately 117% of their potential
2021 bonuses, or $245,000, $275,625, $144,625 and $148,750, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Long-Term Incentive Equity Awards</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that long-term corporate success is
achieved with an ownership culture that encourages high performance by our employees through the use of stock-based awards. Our 2014 Stock
Incentive Plan, 2018 Omnibus Stock Incentive Plan, 2020 Omnibus Stock Incentive Plan and 2021 Omnibus Stock Incentive Plan were each established
to provide our employees, including our Named Executive Officers, with incentives to help align employees&rsquo; interests with the interests
of our stockholders. The Compensation Committee believes that the use of stock-based awards offers the best approach to achieving our
compensation goals of incentivizing long-term performance. We have historically elected to use stock options as the primary long-term
equity incentive vehicle; however, the Compensation Committee has the ability under our stock plans to grant restricted stock and other
equity awards as part of our long-term incentive program, although no such awards have been granted to date. We have selected the Black-Scholes
method of valuation for stock-based compensation. Due to the early stage of our business and our desire to preserve cash, we may provide
a greater portion of total compensation to our Named Executive Officers through stock options or other equity awards than through cash-based
compensation. The Compensation Committee generally oversees the administration of our stock plans. The 2021 Omnibus Stock Incentive Plan
is the only plan under which equity grants may be made at this time because all of the shares reserved under the 2014, 2018 and 2020 plans
have been allocated to outstanding or expired awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><I>Stock Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our 2021 Omnibus Stock Incentive Plans, as did
our prior plans, authorize us to grant options to purchase shares of common stock to our employees, directors and consultants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compensation Committee reviews and approves
stock option awards to Named Executive Officers based upon a review of competitive compensation data, an assessment of individual performance,
a review of each Named Executive Officer&rsquo;s existing long-term incentives, and retention considerations. Periodic stock option grants
are made at the discretion of the Compensation Committee to eligible employees and, in appropriate circumstances, after consideration
of any recommendations of our Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock options granted to employees have an exercise
price equal to the fair market value of our common stock on the day of grant, typically vest over a time or upon the achievement of certain
performance-based milestones and are based upon continued employment, and generally expire 10 years after the date of grant. The fair
value of the options granted to the Named Executive Officers and reflected in the Summary Compensation Table is determined in accordance
with the Black-Scholes method of valuation for share-based compensation. Incentive stock options also include certain other terms necessary
to ensure compliance with the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect to continue to use stock options as a
long-term incentive vehicle because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
options align the interests of our Named Executive Officers with those of our stockholders, supporting a pay-for performance culture,
foster employee stock ownership, and focus the management team on increasing value for our stockholders.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock options are performance-based. All of the value received by the recipient
of a stock option is based on the growth of the stock price. In addition, stock options can be issued with vesting based on the achievement
of specified milestones although we have not used such performance-based vesting to date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock options help provide balance to the overall executive compensation
program as base salary and annual bonuses focus on short-term compensation, while stock options focus on long-term compensation.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The vesting period of stock options over time encourages executive retention
and is designed to increase stockholder value. In determining the number of stock options to be granted to our Named Executive Officers,
we take into account the individual&rsquo;s position, scope of responsibility, ability to affect profits and stockholder value and the
individual&rsquo;s historic and recent performance and the value of stock options in relation to other elements of the individual Named
Executive Officer&rsquo;s total compensation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Executive Benefits and Perquisites</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Named Executive Officers, all of whom currently
are parties to employment agreements, will continue to be parties to such agreements in their current form until the expiration or termination
of the employment agreement or until such time as the Compensation Committee determines in its discretion that revisions to such agreements
are advisable. In addition, consistent with our compensation philosophy, we intend to continue to maintain our current benefits for our
Named Executive Officers, including medical, dental and life insurance and the ability to contribute to a 401(k) plan; however, the Compensation
Committee in its discretion may revise, amend or add to the officer&rsquo;s executive benefits if it deems it advisable. We believe these
benefits are currently comparable to benefit levels for comparable companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pension Benefits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not maintain any qualified or non-qualified
defined benefit plans. As a result, none of our Named Executive Officers participate in or have account balances in qualified or non-qualified
defined benefit plans sponsored by us. Our Compensation Committee or Board of Directors may elect to adopt qualified or non-qualified
benefit plans in the future if it determines that doing so is in our best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nonqualified Deferred Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our Named Executive Officers participate
in or have account balances in nonqualified defined contribution plans or other non-qualified deferred compensation plans maintained by
us. Our Compensation Committee or Board of Directors may elect to provide our officers and other employees with non-qualified defined
contribution or other non-qualified deferred compensation benefits in the future if it determines that doing so is in our best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth information regarding
compensation paid to our Named Executive Officers for the years ended September 30, 2021 and 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Name &amp; Position</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fiscal Year</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Salary</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bonus</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Nonequity<BR>
Incentive Plan<BR>
Compensation</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option<BR>
Awards(1) </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>All Other<BR>
Compensation</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 23%"><FONT STYLE="font-size: 10pt"><B>Leonard Mazur</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">347,917</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">245,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">194,978</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;--</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">787,895</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Executive Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">250,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">160,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">140,035</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">550,035</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><B>Myron Holubiak</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">450,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">750,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">275,625</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">194,978</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,670,603</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">450,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">285,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">140,035</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">875,035</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><B>Jaime Bartushak</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">301,667</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">20,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">144,625</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">101,983</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">34,636</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">602,911</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">290,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">150,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">74,513</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">514,513</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><B>Myron S. Czuczman, M.D. (5)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">400,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">148,750</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">174,857</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">917</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">724,524</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; padding-left: 9pt"><FONT STYLE="font-size: 10pt">Chief Medical Officer and Executive Vice President</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2020</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">86,353</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">30,000</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">41,866</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">--</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-size: 10pt">158,229</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">The dollar amount set forth in the table above represents the dollar amount recognized for financial statement reporting purposes for all options granted to the executive officer with respect to the fiscal year in accordance with <I>FASB ASC Topic 718</I>.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Earned in 2021 by Mr. Holubiak upon the Company&rsquo;s achievement of designated market capitalization goals in fiscal 2021. Earned
by Mr. Bartushak for additional responsibilities associated with the in-licensing of E7777 (denileukin diftitox) from Dr. Reddy&rsquo;s
Laboratories in September 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">On October 6, 2020, we granted to Mr. Mazur, Mr. Holubiak and Mr. Bartushak options to purchase 200,000, 200,000 and 125,000 shares of common stock, respectively, at an exercise price of $1.01 per share that vest in equal one-third amounts on the first, second and third anniversaries of the issue date. On July 22, 2021, based on the recommendation of FW Cook to make our executive compensation program more competitive, we granted to Mr. Mazur, Mr. Holubiak and Mr. Bartushak options to purchase 300,000, 300,000 and 100,000 shares of common stock, respectively, at an exercise price of $2.00 per share that vest in equal one-third amounts on the first, second and third anniversaries of the issue date. The option awards for 2021 include options to purchase shares of common stock of our majority owned subsidiary NoveCite, Inc., the value of which was $11,092 for each of Mr. Mazur and Mr. Holubiak and $7,394 for Mr. Bartushak.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>On October 8, 2019, we granted to Mr. Mazur, Mr. Holubiak and Mr. Bartushak options to purchase 175,000, 175,000 and 100,000 shares
of common stock, respectively, at an exercise price of $0.67 per share that vest in equal one-third amounts on the first, second and third
anniversaries of the issue date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Dr. Czuczman was hired on July 14, 2020. On that date we granted him an option to purchase 500,000 shares of common stock at an exercise price of $1.19 per share that vest one-third on the first anniversary of the issue date and thereafter in 24 equal monthly installments. The option award for 2021 includes options to purchase shares of common stock of our majority owned subsidiary NoveCite, Inc., the value of which was $7,394.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: -27.35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>Health insurance premiums paid by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Outstanding Equity Awards at Fiscal Year-End 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table contains certain information concerning unexercised
options for our executive officers as of September 30, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Name</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>(a)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of Securities Underlying Unexercised Options</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exercisable</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(b)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of Securities Underlying Unexercised Options</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Unexercisable</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(c)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Option Exercise</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Price</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(e)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Option Expiration</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(f)</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font-weight: bold; text-align: left">Leonard Mazur</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">220,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">--</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6.75</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 11%">9/12/2024</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Executive</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.45</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/13/2027</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.62</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/04/2028</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">116,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/08/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/06/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/22/2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Myron Holubiak</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/01/2025</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Executive</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.45</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/13/2027</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.62</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/04/2028</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">116,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/08/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/06/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/22/2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Jaime Bartushak</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/06/2026</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Financial</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.45</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/13/2027</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.62</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9/04/2028</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/08/2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/06/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/22/2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Myron S. Czuczman, M.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166,650</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333,350</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.19</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7/14/2030</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Medical Officer and Executive Vice President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Option Repricings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We did not engage in any repricings or other modifications to any of
our executive officers&rsquo; outstanding options during the year ended September 30, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employment Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Leonard Mazur</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 19, 2017, the Company and Leonard L.
Mazur, the Company&rsquo;s Executive Chairman and Secretary of the Company&rsquo;s Board of Directors, entered into an Amended and Restated
Employment Agreement (the &ldquo;Mazur Employment Agreement&rdquo;) with the following terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Compensation and Benefits</I>. In exchange for
his services with the Company, Mr. Mazur will receive an annual salary of $250,000 and will be eligible for an annual bonus of up to 50%
of his annual salary. Mr. Mazur&rsquo;s bonus will be based on his attainment of certain financial, clinical development and business
milestones, as established annually by the Board. Mr. Mazur will also be entitled to participate in any benefit plans that the Company
may from time to time establish and have in effect for all or most of its senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 20, 2020, the Company&rsquo;s Compensation
Committee approved an increase to Mr. Mazur&rsquo;s annual salary to $375,000, effective January 1, 2021. Mr. Mazur&rsquo;s annual salary
was increased to $400,000, effective August 1, 2021. This increase was made upon the recommendation of FW Cook.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Term and Termination</I>. The Mazur Employment
Agreement has an initial three-year initial term that ended on October 19, 2020, but which will automatically renew for additional one-year
terms unless terminated by the Company or by Mr. Mazur. Pursuant to this provision, the Mazur Employment Agreement was extended for an
additional one-year period on October 19, 2020 and again on October 19, 2021. If the Company terminates Mr. Mazur&rsquo;s employment for
Cause or if Mr. Mazur resigns without Good Reason, he will be entitled only to payment of his accrued compensation as of such date. If
the Company terminates Mr. Mazur&rsquo;s employment without Cause or Mr. Mazur resigns for Good Reason, then conditioned upon Mr. Mazur
executing a release following such termination, Mr. Mazur will continue to receive his annual salary and certain benefits for a period
of 12 months following the effective date of the termination of his employment. In addition, the portion of Mr. Mazur&rsquo;s unvested
options to purchase shares of the Company&rsquo;s common stock that would have vested at the next immediate vesting event following his
termination date will vest and become immediately exercisable upon his termination date. In the event Mr. Mazur is terminated under either
of these circumstances within 90 days prior to a Change of Control or within two years following a Change of Control, Mr. Mazur will receive
a lump sum payment for 18 months&rsquo; salary, continue to receive benefits for a period of 18 months, and all of Mr. Mazur&rsquo;s unvested
Company stock options will vest and become immediately exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If Mr. Mazur&rsquo;s employment is relieved during
a period of Disability, notwithstanding any removal or reassignment, he will continue to receive his full salary, subject to certain adjustments
that may apply, for up to 90 consecutive days or 180 days in the aggregate during any consecutive 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Appointment to Board of Directors</I>. In connection
with Mr. Mazur&rsquo;s employment, the Company agrees to use its best efforts to cause Mr. Mazur to be elected as a member of the Board
and to include him in management&rsquo;s slate of nominees for election to the Board at every stockholders meeting during the term of
the Mazur Employment Agreement at which Mr. Mazur&rsquo;s term as a director would otherwise expire. In addition, Mr. Mazur agrees to
accept election, and to serve during the term of the Mazur Employment Agreement, as a member of the Board without any compensation other
than as specified in the Mazur Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Covenants</I>. The Mazur Employment Agreement
also includes certain non-competition and non-solicitation of customer and employee restrictions during Mr. Mazur&rsquo;s employment and
for a period of nine months and 24 months, respectively, following any termination of employment, in addition to other customary terms,
including provisions covering confidentiality and return of Company property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Myron Holubiak</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 30, 2016, in connection with the merger
by and among the Company, Citius LMB Acquisition Corp. and Leonard-Meron Biosciences, Inc., the Company&rsquo;s Board of Directors appointed
Myron Holubiak to serve as the Chief Executive Officer of the Company and entered into an Employment Agreement (the &ldquo;Holubiak Employment
Agreement&rdquo;) with the following terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Compensation and Benefits</I>. In exchange for
his services with the Company, Mr. Holubiak will receive an annual salary of $450,000 and will be eligible for an annual bonus of up to
50% of his annual salary. Mr. Holubiak&rsquo;s bonus will be based on his attainment of certain financial, clinical development and business
milestones, as established annually by the Board. Mr. Holubiak was also eligible for an incentive bonus based upon Market Capitalization
(as defined in the Holubiak Employment Agreement) of the Company, which incentive was met in fiscal 2021 and is reflected in the Summary
Compensation Table. Mr. Holubiak will also be entitled to participate in any benefit plans that the Company may from time to time establish
and have in effect for all or most of its senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Term and Termination</I>. The Holubiak Employment
Agreement has a three-year initial term, which ended on March 30, 2019, and automatically renews for additional one-year terms unless
terminated by the Company or by Mr. Holubiak. Pursuant to this provision, the Holubiak Employment Agreement has been extended for a one-year
period on each subsequent March 30. If the Company terminates Mr. Holubiak&rsquo;s employment for Cause or if Mr. Holubiak resigns without
Good Reason, he will be entitled only to payment of his accrued compensation as of such date. If Mr. Holubiak&rsquo;s employment is terminated
as a result of his Disability, if the Company terminates Mr. Holubiak&rsquo;s employment without Cause or if Mr. Holubiak resigns for
Good Reason, then conditioned upon Mr. Holubiak executing a release following such termination, Mr. Holubiak will continue to receive
his annual salary and certain benefits for a period of 12 months following the effective date of the termination of his employment. In
the event Mr. Holubiak is terminated in connection with a Change of Control or within six months following a Change of Control, Mr. Holubiak
will receive a lump sum payment for 18 months&rsquo; salary, his full annual bonus, and continue to receive benefits for a period of 18
months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Appointment to Board of Directors</I>. In connection
with Mr. Holubiak&rsquo;s employment, the Company agrees to use its best efforts to cause Mr. Holubiak to be elected as a member of the
Board and to include him in management&rsquo;s slate of nominees for election to the Board at every stockholders meeting during the term
of the Holubiak Employment Agreement at which Mr. Holubiak&rsquo;s term as a director would otherwise expire. In addition, Mr. Holubiak
agrees to accept election, and to serve during the term of the Holubiak Employment Agreement, as a member of the Board without any compensation
other than as specified in the Holubiak Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Covenants</I>. The Holubiak Employment Agreement
also includes certain non-competition and non-solicitation of customer and employee restrictions during Mr. Holubiak&rsquo;s employment
and for a period of 12 months following any termination of employment, in addition to other customary terms, including provisions covering
confidentiality and assignment of inventions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><I>Jaime Bartushak</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 27, 2017, the Company&rsquo;s Board
of Directors appointed Jaime Bartushak to serve as the Chief Financial Officer of the Company and entered into an Employment Agreement
(the &ldquo;Bartushak Employment Agreement&rdquo;) with the following terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Compensation and Benefits</I>. In exchange for
his services with the Company, Mr. Bartushak will receive an annual base salary of $250,000 and will be eligible for an annual bonus of
up to 40% of his annual salary. Mr. Bartushak bonus will be based on his attainment of certain financial, clinical development and business
milestones, as established annually by the Board. Mr. Bartushak will also be entitled to participate in any benefit plans that the Company
may from time to time establish and have in effect for all or most of its senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 4, 2018, the Company&rsquo;s Board
of Directors approved an increase to Mr. Bartushak annual salary to $290,000 after receiving input from FW Cook, an independent compensation
consultant with the increase being made effective October 1, 2018. On November 20, 2020, the Company&rsquo;s Compensation Committee approved
an increase to Mr. Bartushak annual salary to $300,000, effective January 1, 2021. Mr. Bartushak&rsquo;s annual salary was increased to
$325,000 effective August 1, 2021 after the Compensation Committee received input from FW Cook.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Term and Termination</I>. Under the Bartushak
Employment Agreement, Mr. Bartushak&rsquo;s employment will be at will and continue until terminated by either party. If the Company terminates
Mr. Bartushak&rsquo;s employment for Cause or if Mr. Bartushak resigns without Good Reason, he will be entitled only to payment of his
accrued compensation as of such date. If the Company terminates Mr. Bartushak&rsquo;s employment without Cause or Mr. Bartushak resigns
for Good Reason, then conditioned upon Mr. Bartushak executing a release following such termination, Mr. Bartushak will continue to receive
his annual salary and certain benefits for a period of 12 months following the effective date of the termination of his employment and
his annual bonus prorated based on the date of termination. The definition of Good Reason includes any &ldquo;Change in Control&rdquo;,
which is defined as including the sale of substantially all the assets of the Company, any merger, consolidation or acquisition of the
Company by or into another party, entity or person, and or any change in the ownership of more than 50% of the voting capital stock of
the Company in one or more related transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Covenants</I>. The Bartushak Employment Agreement
also includes certain non-competition and non-solicitation of customer and employee restrictions during Mr. Bartushak&rsquo;s employment
and for a period of 12 months following any termination of employment, in addition to other customary terms, including provisions covering
confidentiality and assignment of inventions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Myron S. Czuczman, M.D.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July 14, 2020, Myron Czuczman was hired to serve
as the Chief Medical Officer and Executive Vice President of the Company and entered into an Employment Agreement (the &ldquo;Czuczman
Employment Agreement&rdquo;) with the following terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Compensation and Benefits</I>. In exchange for
his services with the Company, Dr. Czuczman will receive an annual base salary of $400,000 and will be eligible for an annual bonus of
up to 35% of his annual salary. Dr. Czuczman&rsquo;s bonus will be based on his attainment of certain financial, clinical development
and business milestones, as established annually by the Board. Dr. Czuczman will also be entitled to participate in any benefit plans
that the Company may from time to time establish and have in effect for all or most of its senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Term and Termination</I>. Under the Czuczman
Employment Agreement, Dr. Czuczman&rsquo;s employment will be at will and continue until terminated by either party. If the Company terminates
Dr. Czuczman&rsquo;s employment for Cause or if Dr. Czuczman resigns without Good Reason, he will be entitled only to payment of his accrued
compensation as of such date. If the Company terminates Dr. Czuczman&rsquo;s employment without Cause or Dr. Czuczman resigns for Good
Reason, then conditioned upon Dr. Czuczman executing a release following such termination, Dr. Czuczman will continue to receive his annual
salary and certain benefits for a period of 12 months following the effective date of the termination of his employment and his annual
bonus prorated based on the date of termination. The definition of Good Reason includes any &ldquo;Change in Control&rdquo;, which is
defined as including the sale of substantially all the assets of the Company, any merger, consolidation or acquisition of the Company
by or into another party, entity or person, and or any change in the ownership of more than 50% of the voting capital stock of the Company
in one or more related transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Covenants</I>. The Czuczman Employment Agreement
also includes certain non-competition and non-solicitation of customer and employee restrictions during Dr. Czuczman&rsquo;s employment
and for a period of six months following any termination of employment, in addition to other customary terms, including provisions covering
confidentiality and assignment of inventions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Potential Payments on Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the severance payments called for in our agreements
for Mr. Mazur, Mr. Holubiak, Mr. Bartushak and Dr.&nbsp;Czuczman had been triggered on September 30, 2021, we would have been obligated to
make the following payments:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cash Payment </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: center; text-indent: -12.25pt"><B>($ per month) and </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(# of months paid)</B></P></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Benefits</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($ per month) and </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(# of months paid)</B></P></TD><TD STYLE="padding-bottom: 1.5pt"><SUP>&nbsp;</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of Options </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(# that would vest) and</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($ market value) <SUP>(1)</SUP></B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: left">Leonard Mazur</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: left">$</TD><TD STYLE="white-space: nowrap; width: 9%; text-align: right">33,333</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
mos</FONT></TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left"><SUP>(2)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
mos</FONT></TD><TD STYLE="width: 1%; text-align: left"><SUP>(2)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">616,667</TD><TD STYLE="width: 1%; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">371,667
</FONT></TD><TD STYLE="width: 1%; text-align: left"><SUP>(3)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Myron Holubiak</TD><TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">$</TD><TD STYLE="white-space: nowrap; text-align: right">37,500</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>
    <TD STYLE="text-decoration: none; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
                                            mos</FONT></TD><TD STYLE="white-space: nowrap; text-align: left"><SUP>(2)(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
mos</FONT></TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jaime Bartushak</TD><TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">$</TD><TD STYLE="white-space: nowrap; text-align: right">27,083</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
                                            mos</FONT></TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,086</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
                                            mos</FONT></TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Myron S. Czuczman</TD><TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">$</TD><TD STYLE="white-space: nowrap; text-align: right">33,333</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
                                            mos</FONT></TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">76.43</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12
                                            mos</FONT></TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">--</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD>The market value equals the difference the fair market value of the shares that could be acquired based on the closing sale price
per share of our common stock on the NASDAQ Capital Market on September 30, 2021, which was $2.03, and the exercise prices for the underlying
stock options.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"><SUP>(2)</SUP></TD><TD>Increases to 18 months in the event of termination upon or within six months of a change in control. Neither Mr. Holubiak nor Mr.
Mazur receive medical benefits from our Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"><SUP>(3)</SUP></TD><TD>In the event of termination upon or within six months of a change in control, all of Mr. Mazur&rsquo;s unvested options will vest,
which would be 616,667 shares with a value of $371,667.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"><SUP>(4)</SUP></TD><TD STYLE="text-align: left">In the event of termination upon or within six months of a change in control, Mr. Holubiak will also receive his full annual bonus,
which would be an amount of $225,000.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in"><SUP>(5)</SUP></TD><TD>There is no acceleration of the vesting of options pursuant to each officer&rsquo;s respective employment agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUDITOR AND AUDIT COMMITTEE MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Report of the Audit and Risk Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit and Risk Committee has reviewed and discussed
with management our audited financial statements for the fiscal year ended September 30, 2021, which were audited by Wolf &amp; Company,
P.C. (&ldquo;Wolf&rdquo;), an independent registered public accounting firm. The Audit and Risk Committee discussed with Wolf the matters
required to be discussed pursuant to Public Company Accounting Oversight Board (United States) Auditing Standard 1301 (Communication with
Audit Committee). The Audit and Risk Committee received the written disclosures and letter from the independent registered public accounting
firm required by applicable requirements of the PCAOB regarding the independent registered public accounting firm&rsquo;s communications
with the Audit and Risk Committee concerning independence, and discussed with the independent registered public accounting firm the independent
registered public accounting firm&rsquo;s independence. The Audit and Risk Committee also considered whether the provision of services
other than the audit of our financial statements for the fiscal year ended September 30, 2021 were compatible with maintaining the independence
of Wolf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the review and discussions referred to
in the foregoing paragraph, the Audit and Risk Committee recommended to the Board of Directors that the audited financial statements be
included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">Our Audit and Risk Committee
is currently composed of the following three directors: Mr. Dutia (Chair), Dr. Kane and Mr. Safir. All are independent directors as defined
in Rules 5605(a)(2) and 5605(c)(2) of the NASDAQ Stock Market listing rules and Section 10A-3 of the Exchange Act. The Board of Directors
has determined that Mr. Dutia is an &ldquo;audit committee financial expert&rdquo; as such term is defined in Item 407(d)(5)(ii) of Regulation
S-K promulgated by the SEC. Our Audit and Risk Committee operates under a written charter adopted by the board, a copy of which is available
under <I>Investor Relations</I>&mdash;<I>Governance</I>&nbsp;section of our website at&nbsp;<I>www.citiuspharma.com.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">Wolf has served as our
auditor since 2014 and audited our consolidated financial statements for the years ended September 30, 2014 through September 30, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">THE AUDIT AND RISK COMMITTEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Suren Dutia, Chairman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dr. William Kane</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Howard Safir</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fees Paid to the Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Audit Fees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The aggregate audit fees billed for professional
services rendered by our auditor, Wolf, an independent registered public accounting firm, for the audit of our financial statements as
of and for the years ended September 30, 2021 and 2020, our filings with the SEC and other audit fees were $136,260 and $129,700, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Audit Related Fees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The aggregate audit related fees billed for professional
services by Wolf for the years ended September 30, 2021 and 2020 were $29,285 and $42,700, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Tax Fees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The aggregate tax fees billed for professional
services by Wolf for the years ended September 30, 2021 and 2020 were $11,350 and $9,700, respectively. Tax fees are for the preparation
of federal and state income tax returns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>All Other Fees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No other fees were billed by or paid to Wolf during
the years ended September 30, 2021 and 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pre-Approval Policies and Procedures of Audit and Non-Audit Services
of Independent Registered Public Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All fees reported above under the headings Audit
Fees, Audit Related Fees, Tax Fees and All Other Fees were approved by the Audit and Risk Committee before the respective services were
rendered, which concluded that the provision of such services was compatible with the maintenance of the independence of Wolf in the conduct
of its auditing functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>CERTAIN RELATIONSHIPS AND
RELATED TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">Other than as set forth
below, there were no transactions since October 1, 2020 to which Citius was or is a party in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36.7pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
amount involved exceeded or exceeds the lesser of (i) $120,000 and (ii) one percent of the average of our total assets at year end for
the last two completed fiscal years; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
of our directors or executive officers, any holder of 5% of our capital stock or any member of their immediate family had or will have
a direct or indirect material interest.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Novellus License Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 31, 2020, we entered into an option agreement
with a subsidiary of Novellus, Inc. (&ldquo;Novellus&rdquo;) whereby for the duration of the option agreement we had the exclusive opportunity
to in-license from Novellus on a worldwide basis, a novel cellular therapy for acute respiratory distress syndrome (ARDS). The option
exercise period ran for six months. We paid Novellus $100,000 for the option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 6, 2020, we, through our subsidiary
NoveCite, Inc. (&ldquo;NoveCite&rdquo;), exercised the option and entered into a license agreement with a subsidiary of Novellus, Novellus
Therapeutics Limited (&ldquo;Licensor&rdquo;), whereby NoveCite acquired an exclusive, worldwide license to develop and commercialize
a stem cell therapy based on the Licensor&rsquo;s patented technology. Upon execution of the license agreement, we paid an upfront payment
of $5,000,000 and issued to Licensor shares of Novecite&rsquo;s common stock representing 25% of Novecite&rsquo;s currently outstanding
equity. We own the other 75% of NoveCite&rsquo;s currently outstanding equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;Our Board Chairman Leonard Mazur, who is
also our largest stockholder, was at the time of the transaction with Novellus and until Novellus was acquired by Brooklyn ImmunoTherapeutics,
Inc. in July 2021, a director and significant shareholder of Novellus. Any benefit to Novellus from the option agreement and License Agreement
with Novellus indirectly benefited Mr. Mazur as a stockholder of Novellus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Procedures for Review and Approval of Transactions with Related
Persons</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Audit and Risk Committee Charter,
the Audit and Risk Committee is responsible for reviewing and approving all related party transactions as defined under Item 404 of Regulation
S-K, after reviewing each such transaction for potential conflicts of interests and other improprieties. Our policies and procedures for
review and approval of transactions with related persons are in writing in our Code of Conduct and Ethics available under the <I>Investor
Relations&mdash;Governance</I> section of our website at www.citiuspharma.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>DELINQUENT SECTION 16(A)
REPORTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 16(a) of the Exchange Act requires our
directors, executive officers and holders of more than 10% of our common stock to file with the SEC initial reports of ownership and reports
of changes in the ownership of our common stock and other equity securities. Such persons are required to furnish us copies of all Section
16(a) filings. Based solely upon a review of the copies of the forms furnished to us, we believe that our officers, directors and holders
of more than 10% of our common stock complied with all applicable filing requirements during the fiscal year ended September 30, 2021,
with the exception of: Forms 4 for Jaime Bartushak, Leonard Mazur, Myron Holubiak, Suren Dutia, Eugene Holuka, William Kane, Howard Safir
and Carol Webb, which reports were due on October 8, 2020 and were filed on October 9, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCKHOLDER COMMUNICATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stockholders may send any communications regarding
our Company&rsquo;s business to the Board in care of our Corporate Secretary at our principal executive offices located at 11 Commerce
Drive, 1st Floor, Cranford, New Jersey 07016. The Secretary will forward all such communications to the addressee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEADLINE FOR STOCKHOLDER PROPOSALS FOR 2023
ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stockholder proposals to be included in the proxy
statement for our 2023 Annual Meeting of stockholders must be received by us not later than August 22, 2022. Under our bylaws, stockholder
proposals to be considered at our next Annual Meeting, including nominees for director, must be received by us not more than 90 days and
not less than 60 days before the meeting. All submissions must comply with all of the requirements of our bylaws and Rule 14a-8 of the
Exchange Act. Proposals should be mailed to our Corporate Secretary, Citius Pharmaceuticals, Inc., 11 Commerce Drive, 1st Floor, Cranford,
New Jersey 07016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management&rsquo;s proxy holders for the 2023
Annual Meeting of stockholders will have discretion to vote proxies given to them on any stockholder proposal of which we do not have
notice prior to November 3, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>DELIVERY OF DOCUMENTS TO
STOCKHOLDERS SHARING AN ADDRESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC has adopted rules that permit companies
to deliver a single copy of proxy materials to multiple stockholders sharing an address unless a company has received contrary instructions
from one or more of the stockholders at that address. Upon request, we will promptly deliver a separate copy of proxy materials to one
or more stockholders at a shared address to which a single copy of proxy materials was delivered. Stockholders may request a separate
copy of proxy materials by contacting us either by calling (908) 967-6677 or by mailing a request to 11 Commerce Drive, 1st Floor, Cranford,
New Jersey 07016. Stockholders at a shared address who receive multiple copies of proxy materials may request to receive or a single copy
of proxy materials in the future in the same manner as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNUAL REPORT ON FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Annual Report on Form 10-K for the fiscal
year ended September 30, 2021 as filed with the SEC is accessible free of charge on the SEC&rsquo;s website at www.sec.gov. It contains
audited financial statements covering the fiscal years ended September 30, 2021 and 2020. <B>You can request a copy of our Annual Report
on Form 10-K free of charge by calling (908) 967-6677 or by mailing a request to our Corporate Secretary, 11 Commerce Drive, 1st Floor,
Cranford, New Jersey 07016. Please include your contact information with the request.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board of Directors knows of no other matters
that will be presented for consideration at the Annual Meeting, but if other matters properly come before the meeting, the persons named
as proxies in the proxy will vote according to their best judgment. Stockholders are requested to vote promptly via the Internet, by telephone
or by mail. If you attend the Annual Meeting, you may revoke your proxy at that time and vote in person, if you wish. Otherwise, your
proxy will be voted for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Myron Holubiak</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIRECTIONS TO CITIUS PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2022 ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>11 COMMERCE DRIVE, FIRST FLOOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CRANFORD, NEW JERSEY 07016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>From New York City</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any Hudson River Crossing to the New Jersey Turnpike South to Route
78 West. From Route 78 West take Exit 52, the Garden State Parkway South to Exit 136 (Linden, Roselle, and Winfield Park). Follow to Centennial
Avenue and then Commerce Drive. 11 Commerce Drive is marked accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>From North of Newark</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Take the Garden State Parkway South to Exit 136 (Linden, Roselle, and
Winfield Park). Follow to Centennial Avenue and then Commerce Drive. 11 Commerce Drive is marked accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>From South of Newark</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Take the Garden State Parkway North to Exit 136 (Linden, Roselle, and
Winfield Park). Follow to Centennial Avenue and then Commerce Drive. 11 Commerce Drive is marked accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
M  $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!
M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D
MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME\$?%6J_L^_&6Z_>76N>&X4?2?$C9SLU?2V_T>\4G)WX24,0WF':!7->%O\
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M HHHH **** $?[M?GI\,_P#E9Z^)'_9 ['_T[PU^A;?=K\]/AGQ_P<]?$?\
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M\T6ETDQBSG&[:3C.#U]*^1?^"AO_ "D:_8=_['3Q%_ZC=[7&_P#!!WX$ZG\
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MW3//U#1[K19F;Y;:XFBEE"X!&XQ,R!N2" S $'!(P: -2BBB@ HHHH ****
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M +>G>)_A5=/IMY;V-EMOM3@^Q3C1ITCDN_M$K1NC&(+E;BYE!?.$EN"K%7<
MG@VR^%.J)INDZ+H&GR6NJ6;6]@(=!F^RS6D4<*EXI/*\OR-IMP)58(^(\,Q
MQ'I?[(7@>:WMKC_C_CM[^\U*WF\JU7:]U<03SG?'$I8L8/+,A)DV22*7.05W
MO"?P(L/#OC72]=FUK4M:U+2=.&F6SW\-G(T<(+D%76!71B) &9&7>%3=NP*
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MQ@E218'BR@:=GN3:PX 7_7E^ I%>E0Z%8V\T<D=G:QR0JJQLL*AHPH<* <<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP9?^&8QXDU319KZ?PY]EN+'5-874K@1SI/96S2+(TZQI:W D2(LD8ADSMPU
M%/XE_&SP+X;L=2^'MSX5@DTG31<Z:UO<:;:-H\;VNGVFHK"L,DL:RDQ74;)
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M^,+21](TG5/#WB;P;K;>'%:.1;J]\6VGD2:?I18.%*WT<LP10H8/:O\ -\P
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M&XN?"[Z?X7\076D^+-8ETJRU9C;1VTD:6=[=&\1#-YKP8LVP2BEUD5T# KN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHE<[\*_AO;_"?P9'HMK?:EJ:K=7=[+=ZA(CW%Q-<W,MS,[%%1.9)G("JH P
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M0:T\2^39^(KB4ZY%/IJS27%N=9N]5CCMG\Q?L[J][/$9=LA9?+8!'16'N5%
M'@Z_L7W.A%+K1/%4=KJ@LY=-:>^TA;VW-M-:V]O,/)\U!YG^BPLCDD+\ZE75
MR*KQ?L":5::_#<6WB#4H;&UO["2&T>WCD T^"/\ TG3V<G+1W=P3<3,1\[[<
M@[0:^@** /./BA\ 6^)/CFVU5M6%K9J-+:XM#:>:TLFGZI#J,#(^\! 6CD1P
M48D.C*5*$/RFC?L5V^A_%N/Q,-:^W6\UZ]Y>V-W#<;6==6U'5+9HO*N(XU>*
M;4I!F:.8,(HRJQG<3[E10!XOX^_8XLO'FN?$"^DUJXMY/'VF:MIL@%JC_85O
M].TJQ9D)/S;%TM'P<!C*0?NC,EO^RWJ<'C\ZY'XJAMK>'Q*?$%II4&G2BQMM
M]O?V]SA'N6*SSK?N[R1F.(RQ))Y&YIC+[)10!X$_[#@70="T&W\3?9O#6G:/
MHNDWMI'IH6XNQI@D6)HYA(! '63YE",044JR_,&T=7_97UOQ3X.L='U;Q9ID
MRV7AS4_"AFM=!-OYMC=PVR*VS[0RK/'):1N64"-@S*(DX8>V44 >(6?[&X_X
M2+3;F^\0+=V7AV[>718$TU8Y+>*76+35IDN',C">3SK&W1)%6,JH=F$CMO%_
MP5^S+JGP\^(<VN:1XHAM89H[X26W]G2$W;W-])=*;G_2!'*L"RM'$1&DB@_Z
MPH6C;V"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2$2*=N-AX$D9;DOC+JO@KXHZQX"\5-XF\/7FD>#=5;58%AO8Q_:URVEO<VT
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MX0^.M-N-0UO5K/7+&6'_ (0FYAM9))TFAUNZ@M C+'R8Y98%03#Y0(Y<-PV
M"U?_ +;G@K3]LKC7!9V]OJ5QJEPVFRJ-$6QLX;V47*$;T9K>>*1%VDL'7')
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M$%Q#(5SD!CW1POC^M_ OX<^"_A]:Z;X1\:Z?X>D72%O;+6;S4G6VMM)CTYX
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M='=20L;(6XM6MKDV[JLBB\%K8K+&^W?]GCV^6_S#<^)/[$UYXWO_ !_=6/C
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MCUZ^MM1U?:6N9[>#R82Q8G:BY)"J"%!)R0N3R36I110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4$9HHH !P****  #%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^/+BW^'GPZ^$/B3PRL49AO?$'C_4-'OGD(_>*UO#I%T@4'@$2DD<D#I7M%%
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M)O$$MY%&P9&/_'N;-C(N=Q\Q<4 ;G_"ROVO/^B.?L\_^';U;_P"9ZO5?V?\
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M[?Q+&]G8W=S!:S*Q3S;9-1L]X8X99@ZY4$UH7?\ P5NL;;QS\;M-3P.TFF?
MRVUR;5+@^*-.74+\Z79+=OY.GE_M/ER!U192NP,>30!]$?'W7/B5H'A6TD^&
M'ACP7XJUIKH)<VWB;Q)<Z%;16^QR726"RNV:3>$&PQJ,%CNR #Y&?B3^UXP_
MY(Y^SS_X=O5O_F>K0_99_;\7X^_%"'P+XF^'_BCX:^,-0\+1>-M)MM1NK._L
M]<TAY4A:>WN;661=\4DL*R12K&Z^?$0&5MPGD_X*#>&XOV^T^ O]CZQ]L?3?
M,_X2/"_V6-6\@WO]C9SN^U_V>/MF -OE$<Y.* /2;/6?B)+\#&O[GPYX0C^)
M/V"21=%C\07#Z+]KYV1&_-H)O*/RYD^R[ADX0XY\@_X63^UX3_R1O]GG_P .
MWJW_ ,SU<?\ L_\ _!9'PA^T!H7AF>S\)^(M+U'Q!XZOO!$NG7DL0GLC!I>I
MZE#?<']Y;W$6F2HC#'[SS%Y,3UM_L@_\%0K7]I37_AOI?B+X;^+/AO/\8O"Q
M\8>"+O4+RRO['Q%9K#!/)&LMO*SPW,<-Q%(T4T:?*6*LQ5@ #VK]G_7_ (H>
M(-$OY/BEX5\#>%=2CN ME#X8\37.NPS0[1EI))[&S*-NR-H1@1SN'2O-==^(
MG[5T&MWL>F_"/X!W6FK.ZVLUS\5-5MYIH0Q",\:Z X1BN"5#L 20&;&3R?Q.
M_P""K%G\'OBO\0+/6OAKXP/P[^&/B?3O"GB3QM9WEE/:Z1<WUK8W$<\UH95N
MOLJ#4;97EC1]N6;;M4D=%XS_ ."D&EZ'^V1K/P3T?PCKFO>)+'0KBZL+X7$-
MKINK:Y%:I??\(^DTAPEXUC+'=;FQ&(F))RI% '9? OQA\?-<\;-#\2OA[\)_
M#'AP6KLMYX<\>7^MWAG!78GD3Z3:)L(WDMYN00/E.>(?C5XT_:$T7Q[-;_#O
MX<_"'Q)X96*,Q7OB#Q_J&C7SR$?.K6\.D72!0> 1*21R0.E>!:A_P66U+P[\
M&&\:ZW\%]5T/3[CQZWPYL1>^+M+CBN-4BNKZTNO,F+^7!##-8N/,D(5Q(K*2
M*W_'7_!6*^\!ZCJ'_%F_%7B33O"O@/3?B%XKN?#>OZ5J/]BZ=>R7RJT*^>@O
MMB:?/(3;LVY=NP,2 0#T+PE\0OVJ+OQ7I<.N?"?X#Z?HDMY"FHW5C\4-4N[J
MVMBX$LD4+Z%&LDBIN*HTB!B "R@Y'>_M">(_BUX>M=*/PK\'_#_Q9-*\HU)?
M%'BNZT%;90%\LQ-;V%X9"Q+[@P3;@8+9..S\#>,],^(W@K1_$6BWD>HZ+KUE
M#J-A=Q@A+FWF19(I " <,C*>0#S6I0!\U_\ "ROVO/\ HCG[//\ X=O5O_F>
MKUSQ;K?Q&M/@;'?:'X;\'WWQ(-G:N^BWOB&XM=%%RS1_:8Q?K9R3&-%,I1_L
MN7*H"D>XE>XHH ^:_P#A97[7G_1'/V>?_#MZM_\ ,]7KGP*USXC:[X)N)_B5
MX:\&^&/$2W;K!9^'/$-QK5G);A$*.T\]G:NKES("@B( 52&)) [BB@#YK_X6
M5^UYG_DCG[/7X_%K5O\ YGJ[SX >+/C?X@\17T?Q0\"_##PKI*6VZTN/#/C6
M]UVXFGW ;'CGTRS5$V[CN#L<@#;SD>L5\RZIX.O;C]I/Q9-I?A[Q%;^,)O'.
MD7UIKJ6,]K9#0H]/TI;U);LA89X6"7L2VP:1A/*L@C7:TT8!7^/OPX^+VM>-
M-8T_PS\$/@+XG\(LUV+.^USXA:EI.HW*7L2_;?-AAT:=8_,D+959W#&.-SA@
MNVC\,?AE\:;KXH:+-XN^#?P9TK1?)&FZEJ6G?%O6]4U#[%F=@A@FTB%+O:US
M-M2:4 ><^",USOP$_9[M/$W[+/PMM/$'@72;[6M%U32_[;CG\ W&DW,7^B1+
M>?:!=;VNW9D42W"?)*57C*U>LO"WQ9LM'\176J^']:CT_P"(@LO$%]::-KD\
MUYIJP:E ;JRQY<1MYI-'DBMA'!(59M,DVD2S"20 ]G_: N?BUX:LM+TCX5^
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M?['?_E6_^)H#E/TFHK\VOL?_  5:_P"?K]CS\M7_ /B:3[)_P59_Y^_V._\
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M8\_+5_\ XF@.4_26BOS:^Q_\%6O^?K]CS\M7_P#B:/L?_!5K_GZ_8\_+5_\
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M_"?CC4O&O@1K;3+>XLO"2ZG:^1J6DBU?]W-IT\CW$WE#RGBDE4QNOEK4;_\
M!(/PSXQ\,V^A>/O%NM_$#0=:\4:AXW\>:?J-M###X]UBXM$M+=[D1!1%:V<2
M)Y-M&,!H+9V9GBW-XQ]C_P""K7_/U^QY^6K_ /Q-'V/_ (*M?\_7['GY:O\
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M'BWV/_@JU_S]?L>?EJ__ ,31]C_X*M?\_7['GY:O_P#$T!RGM7[+G_!*&+X
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MY&/'OLG_  59_P"?K]CS\M7_ /B:/L?_  5:_P"?K]CS\M7_ /B: Y3Z9_:
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M\%6O^?K]CS\M7_\ B:3[)_P58_Y^_P!CO_RK_P#Q- <IZQX$_P"",GA?X?\
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M /B:/L?_  5:_P"?K]CS\M7_ /B: Y3])<<T5^;7V/\ X*M?\_7['GY:O_\
M$T?8_P#@JU_S]?L>?EJ__P 30'*?I*!BC%?FU]C_ ."K7_/U^QY^6K__ !-'
MV/\ X*M?\_7['GY:O_\ $T!RGZ2T8YK\VOL?_!5K_GZ_8\_+5_\ XFC['_P5
M:_Y^OV//RU?_ .)H#E/TEQS01FOS:^Q_\%6O^?K]CS\M7_\ B:/L?_!5K_GZ
M_8\_+5__ (F@.4_24C-!&:_-K['_ ,%6O^?K]CS\M7_^)H^Q_P#!5K_GZ_8\
M_+5__B: Y3]):,5^;7V/_@JU_P _7['GY:O_ /$T?8_^"K7_ #]?L>?EJ_\
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MS$%S^M'A7P1H_@7PII6@Z+I>GZ5HNAVL5EIUA:6ZPVUC!&@CCBBC4!454 4
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MH\QMK<Q#_B99!!C /._L^?\ !4_XN>*_!5[XFU36O"_B;2?%^A>%+"XN],U
MQMX>U34O#U[</)9Q*C1ATNH$,\;O\K[U4+Y>&_61K6$$MY4>[=YF=HR6QC/U
MQQGTKXA\4_\ !3A?#W_!2^Z^$=JO@^/P/'GPH9A;O_:B>*FT^35ED,F[R#9_
M9]EMM*^8;N;;G'RD \R^&'_!7[Q]X&^$W@OP_P",++X<Z?XBN-#T"]E\8>)/
M$<UIH(AO/#LVIK]MG\A2E[-):31JJJ$8,SKDQ^4_EOQO_P""QOQ$TCX%?'F:
MUNK'P+J7B+1M;\1^'9/%NJG3[_PN8O!?A.\BT;3T$9$VI+=:S<7"Q/C)A?(
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MKZSI0_X0>S&AZG=Z7J$6FZG-IX($:RV]W<+')-((5VF24.T,<DBP?M*_MC_
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M4 <[\.?A!X2^#VG2V?A'POX=\+6DZVZ20:1IL-C'(MO;16EN"L2J"(K:""%
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MQCC20CS"50=#XS_:X\:0?"[XA:A8^$=&T76/ GA2ZUR>#6-0E61I56_^SND
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MC=1NH **-U&Z@ HHW4;J "BC=1NH **-U&Z@ HHW4;J "BC=1NH **-U&Z@
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MSX?>*]:U2V\%ZQ?:U;V$]UJM]I]A9K<&TM+.QNY&DEDE1G5(KZW 7))96 '
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M_P##F7U?3E% 'S'_ ,.O]-_Z+A^TY_X<R^H_X=?Z;_T7#]IS_P .9?5].44
M?,?_  Z_TW_HN'[3G_AS+ZC_ (=?Z;_T7#]IS_PYE]7TY10!\Q_\.O\ 3?\
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M*^']/UKQ-IC^#9#)INJ0W<<FH9>&6&3S'EC=)/,2:0-N0_,59=KHK#BO"_[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 1NE?F_>_\K5EGU_Y-\/_ *>'K](&Z5^;][_RM66?_9OA
M_P#3N] (_2&BBB@ HHHH **** /FO_@LC_RBD_:(_P"R?ZQ_Z2R5:_X)#_\
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M(=T>W<B".@#LO@#^R%H_P \2-JVAZYJ-Q<75E::7J:RI#Y>HV]I:16]L&5%
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M:G\4+3XKZ;-J8\9176O7>F7&IV]QH,$6F7UH-)"3W-Q.L1-O<K(D>84D0>:
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M8?L\WEK+*#-YJ[9?*=V,=O\ 6>E"X72[876TW0B7SB.A? W?KFK%% !1110
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M#0K;A0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTV\T6/Q!;NTFGW3I)+931RO#-$70E7VRQNH9>& !&,XKXAO?^5JRS_[-\/\
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M6&S\7_V2?"?QM\0:KJFL-J\=YJ^C0Z)*UG>&'RXHKM;R.1,#Y9EF1"']% H
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M&55T$;Y<U=5_8(\#ZEX9T[35.H)_95Q#/;3SQVNH.@CTZVT[84NX)HF5H+2
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ML0>.WUN8IIEY%>K;P6ZV$.YI9(4CWNZA$9FPQ 4_70H 1NE?F_>G_CJLL_\
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M73 !.45'&4=6/I%KXGTZ^COFM[ZUN!ILC178AE60VSJ S(X!)5@"#M/.#TH
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M8>.O"NF:WI<_VK2]8M(KZSFV,GG0RH'1MK ,,JP." 1GD T :%%%% !1110
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M8VLHYA*1%<$,MN2;<O*ZV-!\1?'N\^'UKK5]?WNF:Y<+#!+I^H6%E#IM@/\
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MM:LQ<)I<TMMIS6-IBUL;@26@WWPF\HH%>#:;J(L-X!]:$XI"X'?WKY<N=?\
MCI9>/-,MUNKQ['4=4NKB*2\L%-NL:ZK*BV4R6UE*4C_L^.W,<LDT \RXD=I)
M0H1*?@_Q/X[\'?#SXP>-]4NO%']L:=\.+"6#4=?T>"P,.J6L.JSW$4<:QI')
M%#++&=Q5E;S,"210#0!]7[@:7=7RO>?%/XM>'=(\27EG'XXUS37TC6+?07O/
M#$<>IRZO]BTV2R5X(X%"0BX&I(LLBK"3P[%?*=\?2?"OQ GOYM#6U\67&DKX
M[NM8OK&\TJ.&UL@OCJSO+.>VG$:M*DE@UW._[R7:$&X0G"$ ^P,T;J\+_9&U
M/QE-!:V?C8^(-+O[31--2VTA=#BM=(1/[.LC-()8H=JSB[:ZC,/FKL"86+8J
MR/POA?XJ?%OQ'XA:76K/QYX5\*W5W9SW+VNCQZEJFDF2+4C+:*/L*^9&DD5@
MCO%#<!3,-DTD;--& ?5V[B@-FOF>3QG\138V[:IJWQ&TZ5[V]775TKPO#<OI
M4JB;[)%8 VCK<6C]3,3,V8[<2&+S)0(KKXE_&K4M(M]'ETW6-+\3LROJ5U9:
M-'-86*2K8X$$LBM%+L:6[( :0CR3YA^[N /IW-&>:^9-;TSXE0_$;PRMS?>+
MM:M8;ZYL9(KC3+:6PNK>/Q%ISQW-P$@"),M@9S'+E.("RCS-Q9EAK7Q>T2VT
M.77=;\5+I>HVVDW>NW=MH]D][I+R1:J;F&VB6W8,!-'IB.I25DC>1\C+2* ?
M3CRK&,LRJ,@<G').!^9XIV[(KY3\5:7XR^/?[)7P#\32?VAK'B1-+B\0:I"=
M-LI8[N\D\,WQ62>!HVC&;N2)0L>U0TP _A*W/B!_PNZVTKQ-<:'JWB"UDM=/
MU>ZTFPM]'L&A6:UL;;[!;+NB+,LUP\Y;+9;RPJE .0#Z@#9I"P%><_"?Q;J>
MB>.=:\'^(]0U34[Y;NXNM#O+RTC22_TZ*WT\RR.\$4<(*W-X\2C:K,L9P&V.
MU>+:O\5OC%-K'BN]CT[QE8Z?IFIVDEAI,>FK<W&J?O\ 5(I;*&X_L\)"#&FG
MS"5UF@&%C:Z43//& ?5X8&ES7SS^U)X$\6^+/BG9V^DZAXL72[Y-!:*"TMHI
MK"TEMO$=E/<W66B8).EOEAYC%65&PC[& H>%/%/QF_X7=HFDZA)?0>';>6:'
M[;=V.Y=52+5=2B<SBWLG1';3XK"2-S/:)OGW 3#?$H!]*EL4;J^;_B7\4OBK
M9?M :S;:)H?B2/PKI'EF206B74-U CZ9-+-;J+527:)]0B$:7$TC-&W[M&,0
M&#XU\0?$OXC7^DQWEIXRM='N/$^F7.F6EOH,8^W00^+G,S7Q:(O:QQ:7#8S1
MEF@=EDF)$L@\M0#ZNHW<U\A_#F?XJ>%=%T,:O>^/-'@U*W\/R:Y'IOA^"Y30
M+8:!,LZV$"6LBJQU.&%)8E24QJ^0D:,)%]$^$6H?&2X^$OCG5M<#3^-ETJT7
MP]HEY;VUOI\=Z-"LI9 6C 9@^I272.S2E%$85=H4LP![LTJIU91SCD]Z<6P1
M[\#WKYJ\-^&/%WQ+^(_@F]U*^\;:IX;\,^+!>VTVNZ):6%U,#HERLCSQ?9D(
M2.Y<)'(B1G?-( 758V#/'OP]\<>(?CI>?9-=\;6L5KXU75;&X2QMI;?3;!O"
MMS;C[,\MNT>UK[*.C>80VTX7S0[ 'TQNXHS7S_\ LX>,OBSXI^,-V/&T,FDZ
M6FGEVT]K200,[1VIB>&06BHK F?S$:[E?<[#RT5!C)\-:9J7@_PAXJFM/#.O
M0_&!9[EM2UU]&DO)KFR?4%\R2RO)$:WE"VI$EO9[SL,:1M""KI0!]+ YH#9%
M?+XU#XR^(;JX.GZYXNM-%MM3TZWTRXN-"LX;[4K*?5XX;N>YCDMP8Y(;1IS&
M B81(99$9BRFG#\5_BO9?%*XTF.;Q5K&H^'X-/ECTA-'M%M=8MSJFJQ7,EU=
M>4HAF>PMK>2,!X$,ICVA@\B* ?5F:,U\CZ%XN^.WB+PUKMW'-XIL_P"R=+UC
M4=+CDTRW:75;N*QT:6RM9#-8V\C1M=2ZI'A8('<1D @*I/JWP+\6>,/B'XA^
M(VG:SJ%Q:VOA:^D\.6=U!! ))YPTMR+V-]AC?%G=:=&<KM6Y@NU,>%&0#V!9
M5=<JP8>H_*EW U\:>"8?C!\(/@AHGA_0;?Q-;ZUH?AVT@TO3!H5J^FSPC1-\
MT]S*D("WJZCYJ"(2*7\N#]T5DDD/LOQN\*^*++3/AC%9Z]XPU1;'6Y8M=GMK
M:%GU*&32[^-/M<<,.WR3=/;J?+5%0LKDKLWJ >S!P3U'K1N%?'TY^.GPQ^%7
MAGP[H]WJT@BTJR3^UKO34D?3KLZ=&BVTD-K83M):I/'(S@1K)E@IN44@5ZA^
MT=X^^(GACXHZ;H'@>.'4+KQ-HEWJ%I#)'"(]/ETT-(_F,^"R7DES8VI/_+(!
MF4JS9H ]R+8H#9%?)FG_ !,^-$%GX4C^S>)K_P#M#Q#!)+<"P9&@L!<Z;'/;
MW:R:5!O;RWU"42*EHBQ@*CS2(".Y\1:M\4_#/[*6BW\5QJNL>-+ZZLI]:9K:
M*&ZT^"21?/2&*&UF_P!6/EQ]GFDVER,M@@ ]Z#9HS7RW<ZM\>+3PE<:E:ZCJ
M>JZNH>RM;,:1;PV<X_X14W*76V6"*8.VKJL?[PQJ"S1F-!PN/X5T?XE0^/?%
M%UH,GC 66O>)8C%K^J>'[6WU.6S8>$;:>4));IY8\F+55&Z%0?LV\HYC1B ?
M79<"EKY7UKXF?$SPEXU\/VNK:SXEMVFUW3-)LHETFR:WUJW;6KNWNI;M_)S'
M(UA';R#RC$#G?&I'FJGU10 5A^,?B=X;^'9MQX@\0Z'H1NL^0-0OXK7SL8SM
MWL-V,C..F:W*^0O _P "?!'QY_X*5_M"3^.?!_A;QI+H>B^$['36UW2H-1.G
M0/!?S/%#YRMY:M(Q=@N S')R0* /K/1M;L_$>EP7VGW=K?6-TH>&XMY5EBF4
M]U9201[@U:KY@_X)D>&]/\")\>O#>BV-KH_A_P /_%O5;;2],LXA!::;$]GI
M]P\<,2@+&C332R;5 &Z5CCFOI^@ JCXD\4:;X-T>;4=8U"QTK3[?'FW5Y.L$
M,>3@;G8@#)(')[U>KY9_;N\#:+\5?VM/V7O#/BC1],\1^&[WQ+KEW<Z5J=JE
MW8W$T.@7IADDAD!1VC+,5+ [2<C!YH ^C_!_Q!T'XAV<MQX?US2-<MX'\N27
M3[R.Z2-L9VDH2 <=C6O7R3X,^#GA'X%?\%:]'LO!/A?P_P"#['Q!\(]4N-3M
MM$TZ+3X-0EMM9TU;>25(E57>-;BX"LP)43. <$U];4 %(SA!D\#KD]J6OG'_
M (*\7<ME_P $Q_CDT,LT,DGA"]A+1N48HZ;&7(YP58@^Q- 'M/A?XT>#_&^L
MMINB^+/#6L:@JLQM;+4X+B8!>IV(Q; [\<5TM?&O[<O[+/PQ^"GAKX3Z_P"#
M/ASX%\(:[I?Q8\&V]IJ.BZ#:Z?=6T4^M6MM-&DL**P22"66)E!PR2,I!!Q7V
M50 C=*_-^]_Y6K+/K_R;X?\ T\/7Z0-TK\W[W_E:LL_^S?#_ .G=Z 1^D-%%
M% !1110 4444 ?-?_!9'_E%)^T1_V3_6/_262K7_  2'_P"46'[.O_9.="_]
M((:J_P#!9'_E%)^T1_V3_6/_ $EDJU_P2'_Y18?LZ_\ 9.="_P#2"&@?0^BJ
M***!"%03G%+110!XS^VCXR;P#X-T?6'UZ.QL=/O7N+O1TUAM)OO$B)#(1;6<
MR$.]R&Q)' ,+.R"-V56+#S6__;C\5IXEUBUN(_"/A?3[/Q2^@/=ZQL9M%B6[
MNH8YKB&*],K+/%;B9'E2U10PP94;S5^L*HZSX;L?$%QI\MY;1W$FEW(O+1FS
MF"8(\8=??;(X^C&@#Y,O/VT?'GAR=+Z]D\/BUUFQTF>*'^SHX8-&AF&IA]2=
M[B]MP]O<R64"1B66+RS>0+EW!66_XU_:1^)VI:'KQN?#W@5;+3M,N+Z72[C3
M[C4U>2VT33M2>'SDF$4N^XNI8494QMB5QO.5KZRHH ^.V_;'\7?#:V\16L-W
MH_B1K77M=2>&2%S>^%X5\3)9P27C37,4;6[6URTD89K=1';#:[QJTB>R?LX?
M&'Q9\5KO6+SQ!%X?TW1]-M+98Q9CS7NI9(5F-R+A)Y(/),;*0D9DVER/.?9N
M?V"B@#XMTWXR74NHZO%J?Q O=*^&HUJ=+;Q!H_B1]7@$@TWS+>)-1DB5F>27
MS)6M\.B2PPP!I4F,)]^M_C%80_LQ3^(/&^L+H-UH^B0-XL:PE*W.C7C6L,TT
M&V/<\<W[U=L8S)^\3;DLI/JF.:K:=H]KI!N#:VUO;&ZE-Q/Y483SI#C+MCJQ
MP,D\\#TH ^/-(^+GB6UT'P_)=>-KJ;4KBWAO/"-K9ZK%?0ZS<3Z[.KZ9<3Q;
MTO9+6Q-E:RMO?:'GGWLRB=+DG[2OAM_ WQ#\00^/=2U#PK/J=GI7A^P3Q6D%
M_<ZB3<[YS<YWV-K<,%VHY6-(K"2<#9*RG[ HH Y7X,ZTVH_#O1;:\\3:9XLU
MRQTRS35-4L3$([^=K='-P$C^5%FSYJ@8&UQCC%=5BBB@ (S2%0QI:* #%&**
M* #&#2;!G\<TM% $-K80642QPPQ0QJ2P5$"J"223@>I)/U--U71[37=,FLKZ
MUM[RSN4,<T$\8DBE4]593D$'T(JQ10 ;:3;D4M% !01FBB@ HQ110!'<V4-Z
M@6:*.95=9 '4, RD,K<]P0"#V(!J2BB@! NT4;1GITZ4M% !BH[FUCO;>2&:
M..:&92CHZ[E=2,$$'@@CM4E% %/0?#NG^%=(@T_2[&STVPM05AMK6%888@22
M0J* !R2>!WJYC-%% ",H9<'I4=U8PWMI+;S0QS03J4DC=0RR*1@@CH01P0>M
M2T4 &.**** $* ]A04!/2EHH ;Y2_P!VE9 PY%+10 $9K/\ $?A32_&&F-8Z
MOIMAJEFSAS;WEND\18'(.U@1D'H>U:%% "*@10%& .@':EHHH ,4;>:**  K
MDYHQFBB@ QQCMZ48HHH ,4!<&BB@ V\TC*&I:* $VBE(S110 ;><U&EG#'<R
M3+%&LTH57D"C<X7. 3U.,G'ID^M244 %5M+T>ST.U\BRM;>S@WO)Y<$8C3<[
M%W; &,LS,Q/<L2>2:LT4 &,T!<#%%% "; :KIHUFFJF^6UMQ?-"+<W C'G&(
M$L$WXSM!).,XR2:LT4 -\M<GY?O=?>EV"EHH 0J#1M&*6B@"A-X5TNY\0PZO
M)IMA)JUM$8(;UK=&N(HSG*+)C<%.3P#CDU?HHH *\=^,W["?P_\ CC\1I?%V
MH-XZT'Q)=6<.GWE_X2\<ZWX6EU*"%I&A2Y_LVZ@%QY9FEV&4,R"1@" 2*]BH
MH XOX#_L_>%?V:O W_".^$;"ZL].DNY]1N9;S4;G4K[4+N=S)-<W-U<R23W$
MSL<F261F( &<  =I110 5Y_^T%^S'X/_ &G-%TFS\56NK^=H-[_:.E:CHVMW
MNAZII5P8I(6DM[RREAN(BT4LD;!) '1V5@0<5Z!10!Y1\!OV+/ ?[.?C#4O$
M>AKXMU;Q)JEDFFS:QXI\7:MXGU".T1VD%M%/J-S.\,)D8NT<1568*6!*J1ZO
M110 5A_$KX;Z%\8OA[K?A/Q/I=KK7AWQ'92Z=J5A<KNBN[>5"DD;8YP5)&00
M1U!!YK<HH \%\&?\$VOACX-\:Z'KTDWQ-\377AF\34=+M?%7Q+\1^)-.LKI
MRQW"V=_?36YECW$QN8RT;892K $>]444 (W2OS?O?^5JVS_[-\/_ *>'K](&
MZ5^;][_RM66?3_DWP_\ IW>@$?I#1110 4444 %%%% 'S7_P61_Y12?M$?\
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M+^P])\*7_P#;=I),=2CNY_LEO91QBU8,K2()9#(MW$R 1 827++B+S>X\2?
MGP;XQU*:[U;PSHNI374CS7!N;59%N9'@2V9Y%(VNQ@C2/<P)"*%Z<5#IG[/7
M@C1+ZRNK/POH]K>:?=/>P7,-N$G69Q$'<R#YV+B"#=N)#>1%G.Q< '(Z#^T]
M=?\ #.GP\\<ZOH"V3>,[6QN+\+=DV&@I/;&=IKBXV$I" NP.R!=\D8<HI9U6
M;]KJQO9=!L=,T'4;O6O%2JNEV<\T5NLDC-=Y663)\M5CLKB1B QVJ JNY"GM
M9_@=X1NO UCX9D\/Z:_AW36S;:88O]%B'S?)Y?W3'AB/+(*8XQ@ 52F_9K\
M7#ZF[>#_  _YFL2K/=RBS022R+,\ZMO W*5FDDE&TC$DCN,,S$@'-_!G]H#5
M/&/Q#O\ PUK6BR6MPUUK+6%XDD9AFBL+NW@=2H;<,?:H@K$ N8Y250;-_/\
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M (9<\(_\*<\&^ Q8L/#/@<62Z=9X3:5M(_+@#_+U7"MN7:P=58$$4 <IX?\
MVTAXOU.TL=+\&ZPUY?:A'HD*75W;PH=2-M/=36Y96?Y88;6X9Y "&*H(Q)OR
M,JX_X*):%8^'+KQ!=>%?$UMX;LV:WFNF:U:X6Y70SK30B%9CNVP*T1<-M\[
M7=&3*OK$GP&\%R^&QI'_  B^B1Z:K0.L$=JJ+&T"+'"R[0"K1HJJI&"H&!6'
MX<_9)^'_ (>\1ZUJ2^%]%N&UAD'D36$+6]G"NG0Z<+>&/8%6+[-#LVD'"S2J
M"$<K0!Q?B']K[5+^*.QT_P *ZIH^J0W5JM[=:A'ML[>-]2M[0^7O"23"19FV
M.$"C:^2&3:>FT7]K71]6^'/B;Q-_9.L16?A*TB;4;?;$;B*_9"TNFXWA/M$1
M,2.2PC#3+\^ Q'9:=\&_"NE:>MK#H.F>3&J*JO )"%2;ST&6R2%E^< GA@",
M8%4O ?P,T'P5X$U?P_):Q:Q9^(KR^OM9%];0LNJRWDCO<>=&J+&RL'*;2N"B
M@'<<D@'(^(/VKY/!-S=KKGA6]MK?1KFRL-7N+:]BGCLKJ^E\NTB4':\H8O;A
MW"A4-RF-X24Q\ZG[?MGIOAV\UC6O!?B#2]+L \<L@N+:>4W']B_VVD"HLG+?
M8_E9B0JS$(I=,RCU"']G?P-#>V5U_P (KHLEUI\1@MYI;<221H3*<;FR3CSY
M]N2=OG28QO;-RX^"OA"\TZ:SF\,:#/9W$AEEMY;")XI7-E]@)92N&S9_Z.<]
M8OD^[Q0!PGBO]HS5)/@HOB/3?#NH6.K0^*=+T%[&]A\O[0)]5M+21HGEV!HV
MCG)63 QS\I92E8<'[=</B"YO-/TCPAX@N=5L8;RWO 4#V^G:A;G4(S!+)'N'
ME"73I$,V<#S[<@$-(8O6+OX-^%]2\"_\(S=:'87GA_S8Y_L-S'Y\7F1S+/')
MA\G>DRI(K=59%((*C$.F_ ?P9H]U:36?AG1K66QLSIT30VRQXMSYG[IL?>7]
M],0&S@S2$<NQ(!X[8?MOR?#WX2MJGB30-:U=]!TP+JU[:/:AKC4DT+^VI(8X
MMR#8UOA%?@>8RJ1L!E'>?#C]IM?B!\5;[PF?#.M6-QIF^WO+S9YUI;7<<%M/
M);M(HVC"W*JKYPS12C 'EM)T&H?L\>!=6U&:[NO"/A^XN+BS-A(TEE&V^ P&
MV*$8P<P$PYZ^62F=IQ6Q8?#O0]+\9WOB*UTNSM]:U) EW=Q1[)+G"H@+X^\V
MV*)=QRVV-%SA0  >'Z)^V#XD?QG;_P!H>%XTT=)=:M[U;2[C<VJ6>O+I<=P7
M?:6+*6D,2KTCDPV?+5^N^'7[7>F_$7P-XH\20Z#KUKH_A_2AKEO<S0%8]4M&
M6X9/*9L#S=MN6:/)V+-"207*KVUO\&O"=K)?/'X=TA6U*2>6Y(ME_?--*LTQ
M/'\<JB1AT+Y8\DDR:/\ "/PSX?TW6+*RT/3;:RU\R'4+9(1Y-WYA<R!D^[AC
M)(2 ,$NQ/))(!Y+?_MWVWANTU*ZUSP;KVF6NEW8TIRMQ;W$DVH/ID>J0VJ*K
M]7MI44N2$6;*Y*#S3<T3]M.'Q!XRL?#\/@SQ4NJR1Q->QO:2*MGY]Y>V=O)D
MIN:!Y+"9_-*J%A:.0CE@GIFK?!OPGK]K>07WAO0[R#4)7GNHY[*.1+AWL_L+
MLX(PQ:T_<'/6/Y.G%0Z7\$?">BZQINHVNA6,6H:3$8+6Z"DSI&6=]I<G<X#R
M2, Q.&D<C!8D@'B_@G]NR[U;P%I.K77A.^NM4U#PU#XEN[&SN(%M]/A&G6][
M,$ED8-(2MP%0%%R^ 2JYD'H?@;]I>'QW\3;?0[?P_J4.EZC)JT%AJSSP^7<2
M:9<1VUT&BW>8@,SNJ-@AA"Y.P&/?T6A_ ;P7X9TQ+/3_  MH=K:QV;Z>D4=F
M@5;9D6,P#C_5^6B)LZ!450   ,KP_P#LV>'_  [\;[CQY"D?]K2VLUI&D=C:
M0+$LHMQ(6DCB6:1BMK"H,DC850,'"D ''W_[;,%O-91V_A'6KP^()'70"ES;
MK_::1ZI:Z9+(^7_<*LUY;R8;+&%R=OF*T0Z+XQ?M1:;\&_&-CI-U8SZCY\!F
MN?L<GF36.Z*YDA,B8VJDIM)45G=-SX"AP)"G36/P-\&Z9K=WJ5OX8T.&_OKE
M;R>=;- [S+-]H#YQP?/_ 'IQC,A+G+$FI/$WP6\(^-/$L>LZOX;T74]4CB6%
M;JZM$ED"*)0HRP/W1/, >JB:0# =L@'F]M^VM:V["'5/"NM:7?3W"V5K"9[>
M5;FZFCTZ2UM@ZO@2RKJ*\?=4VMR2Q14=]+XZ_M@:'\ ?%2V.I6=UJ5O%93W=
MX^G'SI[$QV5Y>JLB$!$$D5C,J%Y%+.R *5WNG3:_\!/#NO\ C#P[JS6<,#>&
M]2_MB*"&WB$=Q>+9O90S2$J6+102.B[2.JYR% JYXA^!_@[Q;XK_ +<U3POH
M>I:MY9A-S=6:2NRF*6$YW @GR9YH\GG9-(GW78$ \9TK]L[5M(^)?B?1?$.@
MWD-]9ZV-)T[2[<P.N^2#PVL0DN?,QM^T:T6+;,[-WRED19>T\,_M>Z7K]Q>6
M\NBZK97>FW.G6-U'(\+K'/=ZS>Z/M5E<AE2XL96+<$HR$ ,2HN6O['_@.S\3
M->0Z#I\-A)93VL^EI:0BUO)9GLF:[F.WS)+A1IUDJ.7RBP+CD*5W8/V=O =K
M>Z7<1^$?#\<^B^6;)UL8P8&CE>>-AQRR2R22*QR5>61@078D X+PC^VHGBBW
M\.74G@W6]/L=<TW0M5GDFN;=GT^+6KN:TL%9%<[Y/,B4RA25C$@VM)@BLNW_
M ."@-C9>%FU_6O!OB#1]#BT==<FN#<6UQ)';/I5SJD8\M)"3((;2='4'"R&,
M*9$9G3V2V^%/AFSM888M TB.&W@L;:)%M4"QQ6,IFLT QPL$C%XQT1B2,&HQ
M\'O"@L8[4^&]#:UBB2!(6LHVC$:0/;HFTC&T0221 =-CLO0D4 >8R?MJ-: K
M=>!_$5JUBLUQJC3,L4=K;Q2VD;RQ%PK7'_'XA&Q0I\BX7=O1%DG?]I7Q#_PH
MN3Q4/#.G-JB^.3X32P_M(B)XO^$C_L?SO-V<-M_>;=N-W&<5Z'IWP5\)Z5HW
M]GP^']+^Q_9WM3&\(DS"[*[1DMDE"R(=IX^5?05-)\)/#,OAO4M';1-/.DZO
M=R:A>6GDCR9KF27SGFV]!(TW[PL,'S"7^\<T >.Z;^VM<>%M)D7Q+X?N_MU_
MJNI6.B/ Z;-3%OK?]F#<J[FB"^=:N6(8NC.0NX>69KG]O&&+3Q,O@3Q=')-J
M%OI-O;7$:1W,UV^D?VO+%Y0+.OEVX*;F #2L@'R%I5]8U?X+^$M>TY;2\\.Z
M/<6\?G>6CVJ'RC+<1W4A4XRK-<0Q3$C!\R-'SN4$0ZA\"O!^J:*NGW'AW2Y+
M59XKM081O2:.W6U24/\ >$@MU$6X'=Y>5SM)! /(_BA^VC?-\*M>U'PSX;U&
MUGN+75K;0+[4&CB$E]8%H[A98&R\7ENDQ4.N'-K(&V;HS)]!:=$\&GP)(S-(
ML:AV;;N8XY)V@#/T 'H!7-O\#/!LFM:EJ3>&-#:^UB)X+V<V:%[E'\L2*QQT
M?RHMW][RH\YV+CH-,T2UT43?9;>.W^TS/<3;%QYLC?><^I/K0!:HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS_[-\/\ Z>'H!'Z0T444 %%%% !1110!\U_\%D?^44G[1'_9/]8_])9*M?\
M!(?_ )18?LZ_]DYT+_T@AJK_ ,%D?^44G[1'_9/]8_\ 262K7_!(C_E%A^SK
M_P!DYT+_ -((:!]#Z*HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M]4M7FDB62,1S/(I/EA]LB(=DL?\ %O1/1: "BBB@ HHHH ****  G%>$^/\
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M<<;@X8-WW9SSFOHJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** $;I7YOWO_*U;9_]F^'_ -/#U^D#=*_-^]_Y6K+/I_R;X?\
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M4GH&4X8 CR*+X"_!&#1-%TBW\=0P:/)I<EY;6">)H!%J<::3<Z6U^Q/SR%;
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M4O+@QZM=6DIC0%E/F*D<@$I) ,:[XY Q U$_8HMVU'3T?7F.CZ%JSZKI5H+
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M+Y4N? \$?C'5%T/P9::1 NF;)%AN)M/NOM"SA%F6$23$(LC212,!$FQHSNW
M&9^RQX5^%.D^!OAQ:>'?&FG^(K^:TL/$>DR'40MSJQBT-='6Z6!W:78UK ^5
M))#I(225;'T/7@_P?_8DC^%?C7PSJTWB!M93PW86MI'!-'=Q*);6SDL8+B.-
M;OR$D-JX20O#(6.\J8P^U?>!0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 C=*_-^]_Y6K+/_ +-\/_IW>OT@;I7YOWO_ "M6V?\
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MTHHH  ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ?\ \CT?\+ET?_GS\5_^$OJ?_P CUU=% '*?\+ET?_GS\5_^$OJ?_P CT?\
M"Y='_P"?/Q7_ .$OJ?\ \CUU=% '*?\ "Y='_P"?/Q7_ .$OJ?\ \CT?\+ET
M?_GS\5_^$OJ?_P CUU=% '*?\+ET?_GS\5_^$OJ?_P CT?\ "Y='_P"?/Q7_
M .$OJ?\ \CUU=% ''WGQQT/3[=IIK;Q5'&I )/A?4^I( '_'OU)(&/>J_P#P
MT%H/_0/\<?\ A&:Q_P#(M:WQ6_Y$J7_KZM?_ $IBKHJ .'_X:"T'_H'^./\
MPC-8_P#D6C_AH+0?^@?XX_\ ",UC_P"1:[BC% '#_P##06@_] _QQ_X1FL?_
M "+1_P -!Z#_ - _QQ_X1FL?_(M=Q1B@#G?!?Q3TCQ]J-Y9V U:&ZL8XYIH=
M0TB[TZ0)(7",HN(HRP)C<97.".<<5T5<;I@_XR#UK_L7K#_TIO:[*@ HHHH
M**** "BBB@ HHHH **** "BBB@ J#4]2AT;3;B\NI!#;6L332N1PB*"6/X &
MIZYSXP_\DD\4_P#8(N__ $2] %?_ (7+I'_/GXK_ /"7U/\ ^,4?\+ET?_GS
M\5_^$OJ?_P CUT]J,6\?NH_E4E '*?\ "Y='_P"?/Q7_ .$OJ?\ \CT?\+ET
M?_GS\5_^$OJ?_P CUU=% '*?\+ET?_GS\5_^$OJ?_P CT?\ "Y='_P"?/Q7_
M .$OJ?\ \CUU=% '*?\ "Y='_P"?/Q7_ .$OJ?\ \CT?\+ET?_GS\5_^$OJ?
M_P CUU=% '*?\+ET?_GS\5_^$OJ?_P CT?\ "Y='_P"?/Q7_ .$OJ?\ \CUU
M=% '*?\ "Y='_P"?/Q7_ .$OJ?\ \CT?\+ET?_GS\5_^$OJ?_P CUU=% '*?
M\+ET?_GS\5_^$OJ?_P CT?\ "Y='_P"?/Q7_ .$OJ?\ \CUU=% '*?\ "Y='
M_P"?/Q7_ .$OJ?\ \CT?\+ET?_GS\5_^$OJ?_P CUU=% '*?\+ET?_GS\5_^
M$OJ?_P CT?\ "Y='_P"?/Q7_ .$OJ?\ \CUU=% '*?\ "Y='_P"?/Q7_ .$O
MJ?\ \CT?\+ET?_GS\5_^$OJ?_P CUU=% '*?\+ET?_GS\5_^$OJ?_P CT?\
M"Y='_P"?/Q7_ .$OJ?\ \CUU=% '*CXR:03_ ,>?BK_PF-3_ /C%9\?[1'AV
M=6:.T\93*KM&6C\'ZNZ[E)5AD6V.""/J#7=5S'PA&?!"_P#7[>C_ ,FYJ ,[
M_AH+0?\ H'^./_",UC_Y%H_X:"T'_H'^./\ PC-8_P#D6NXQ10!P_P#PT%H/
M_0/\<?\ A&:Q_P#(M'_#06@_] _QQ_X1FL?_ "+7<48H XW3/CQX?U35;6S\
MGQ/9R7DJP1/?>&=2LH"['"J99H$C4D\#+#)( Y(KLJX_XS<:/H?_ &,&F_\
MI5'784 %%%% !1110 4444 %%%% !1110 4444 (W2OS?O?^5JRSZ_\ )OA_
M]/#U^D#=*_-^]_Y6K+/_ +-\/_IW>@$?I#1110 4444 %%%% 'S7_P %D?\
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MSX=:EKVC#XS:A-8:A;Z-]AN_BAXNTZ=-0N7MTMH)DFO%DAWF[MFW,G"2JX#
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MG_X?"_LJ_P#1Q/P;_P#"KL__ (Y1_P /A?V5?^CB?@W_ .%79_\ QR@#F/\
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MP;_\*NS_ /CE'_#X7]E7_HXGX-_^%79__'* /I"BOF__ (?"_LJ_]'$_!O\
M\*NS_P#CE'_#X7]E7_HXGX-_^%79_P#QR@#Z0HKYO_X?"_LJ_P#1Q/P;_P#"
MKL__ (Y1_P /A?V5?^CB?@W_ .%79_\ QR@#Z0HKYO\ ^'PO[*O_ $<3\&__
M  J[/_XY1_P^%_95_P"CB?@W_P"%79__ !R@#Z0HKYO_ .'PO[*O_1Q/P;_\
M*NS_ /CE'_#X7]E7_HXGX-_^%79__'* /I"BOF__ (?"_LJ_]'$_!O\ \*NS
M_P#CE'_#X7]E7_HXGX-_^%79_P#QR@#Z/;I7YOWI_P".JRS_ .S?#_Z>'KZ/
MG_X+%?LJ00M(?VB/@[A 6('BJT8G'H ^2?8<FODO_@GU\3[?_@I/_P %Q?B1
M^TAX#LM0E^#G@'P!'\-],\0W%K);Q>(K\W:74AA60*VU 90PQN4>26"^:!0!
M^HU%%% !1110 4444 %>2?'#]@CX(_M,>)%UKXA?"3X=>--95%B_M#6/#]K=
MW911A5,KH7*@= 3@=J];HH ^;?\ ASI^RG_T;M\'?_"5M/\ XBC_ (<Z?LI_
M]&[?!W_PE;3_ .(KZ2HH'=GS;_PYT_93_P"C=O@[_P"$K:?_ !%'_#G3]E/_
M *-V^#O_ (2MI_\ $5])44!=GS;_ ,.=/V4_^C=O@[_X2MI_\11_PYT_93_Z
M-V^#O_A*VG_Q%?25% 79\V_\.=/V4_\ HW;X._\ A*VG_P 11_PYT_93_P"C
M=O@[_P"$K:?_ !%?25% 79\V_P##G3]E/_HW;X._^$K:?_$4?\.=/V4_^C=O
M@[_X2MI_\17TE10%V?-O_#G3]E/_ *-V^#O_ (2MI_\ $4?\.=/V4_\ HW;X
M._\ A*VG_P 17TE10%V?-O\ PYT_93_Z-V^#O_A*VG_Q%'_#G3]E/_HW;X._
M^$K:?_$5])44!=GS;_PYT_93_P"C=O@[_P"$K:?_ !%'_#G3]E/_ *-V^#O_
M (2MI_\ $5])44!=GS;_ ,.=/V4_^C=O@[_X2MI_\11_PYT_93_Z-V^#O_A*
MVG_Q%?25% 79\V_\.=/V4_\ HW;X._\ A*VG_P 11_PYT_93_P"C=O@[_P"$
MK:?_ !%?25% 79\V_P##G3]E/_HW;X._^$K:?_$4?\.=/V4_^C=O@[_X2MI_
M\17TE10%V?-O_#G3]E/_ *-V^#O_ (2MI_\ $4?\.=/V4_\ HW;X._\ A*VG
M_P 17TE10%V?-O\ PYT_93_Z-V^#O_A*VG_Q%'_#G3]E/_HW;X._^$K:?_$5
M])44!=GS;_PYT_93_P"C=O@[_P"$K:?_ !%'_#G3]E/_ *-V^#O_ (2MI_\
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M]E/_ *-V^#O_ (2MI_\ $4?\.=/V4_\ HW;X._\ A*VG_P 17TE10%V?-O\
MPYT_93_Z-V^#O_A*VG_Q%'_#G3]E/_HW;X._^$K:?_$5])44!=GS;_PYT_93
M_P"C=O@[_P"$K:?_ !%'_#G3]E/_ *-V^#O_ (2MI_\ $5])44!=GS;_ ,.=
M/V4_^C=O@[_X2MI_\11_PYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\.=/V4_\
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M@[_X2MI_\11_PYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\.=/V4_\ HW;X._\
MA*VG_P 11_PYT_93_P"C=O@[_P"$K:?_ !%?25% 79\V_P##G3]E/_HW;X._
M^$K:?_$4?\.=/V4_^C=O@[_X2MI_\17TE10%V?-O_#G3]E/_ *-V^#O_ (2M
MI_\ $4?\.=/V4_\ HW;X._\ A*VG_P 17TE10%V?-O\ PYT_93_Z-V^#O_A*
MVG_Q%'_#G3]E/_HW;X._^$K:?_$5])44!=GS;_PYT_93_P"C=O@[_P"$K:?_
M !%'_#G3]E/_ *-V^#O_ (2MI_\ $5])44!=GS;_ ,.=/V4_^C=O@[_X2MI_
M\11_PYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\.=/V4_\ HW;X._\ A*VG_P 1
M1_PYT_93_P"C=O@[_P"$K:?_ !%?25% 79\V_P##G3]E/_HW;X._^$K:?_$4
M?\.=/V4_^C=O@[_X2MI_\17TE10%V?-O_#G3]E/_ *-V^#O_ (2MI_\ $4?\
M.=/V4_\ HW;X._\ A*VG_P 17TE10%V?-O\ PYT_93_Z-V^#O_A*VG_Q%'_#
MG3]E/_HW;X._^$K:?_$5])44!=GS;_PYT_93_P"C=O@[_P"$K:?_ !%'_#G3
M]E/_ *-V^#O_ (2MI_\ $5])44!=GS?#_P $>OV5;>577]G?X.;E.1GPI9D?
MD8\5[YX*\#:+\-O"UCH?AW1]+T'1-,C\FST_3K5+6UM(^NR.*,!$7V4 <UJ4
M4""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS9T"[9'RH.YP3D#F@#\L/$_Q+O\ X=_MM>+(["'0YE\1?MG^&-&NO[1TBUU
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ML'"X VCIBK<OP_T&;4YKYM%TEKVXL1IDMP;2,RRV@)(MV;&6B!9CY9^7)/%
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MD,B;B#\BLV"-HQ7ZVZE\%_!VL6L,%YX3\-74-OJ7]LQ1S:9!(D=]NW?:E!7
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MB^&_@/PK\7M+C;Q%\:O%/PUMOB3:^'+"[7Q7HUCH\MW%J44.W[,T\<HDB$D
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M52T#PWI_A33OL>EV%GIMIYDDWD6L"PQ[Y'+NVU0!N9V9B>I+$GDU=H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHKS'XL?M>>#?@IXSL?#^O0^./[2U246]D-.\$:UJL%[+Y$MQY
M44UK:R122"&"9RBL6 C;(&* /3J*YGX9_%C2_BO;ZQ+I:WJ+H>IRZ3<BZMS
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M/- !11G-% !16?IOBO3=7UW4M+M;RWFU#2/*^VVZ-F2V\Q=T>\=MRC(]JT*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KROX_^&-1U[XP_ V[L
M;&ZN[71/&5W>:A+%&62RA;P[K,"R2'^%3+-%&"?XI%'>O5*1E#=: /CQOV:K
MC2?$?B+QQ9^%=1'CK_A<UC>6.J>3(;R'1Y;RPM[SR6ZK9/:-=-(BXB8F20@M
M\U8__!-3X0>)/"?CC2=2\437VC^-M/\ #%Q8>-K,_#[4])'B'59)[9I;VZUB
M:XEM-4E2:*<PRV_'E74FT1H0B_;7EC-+MZ>U 'S-_P ,M7WQ9_:N^*5]X@UG
MQEIG@NXU#0+Q=&MXK2'2O$K6EO%*#+,]LURRI/&@9(;B-&";'5E9U;RKPO\
ML\6/P_\ !WPMU+QY\/\ 7O$7A'4)-;O/&^G#0+G7;RYUF65/[*N;^SBCDGNK
M6"W%[!'&8Y4@:>T8(HB62/[N"X'UHV#- 'Y[/\(OB!'X.\$W$/A/XA+H?AU]
M3U#Q1IGGRK=ZQX,EU^YGTC05C(9Y[NWLUBE:W!,JV\,UD^6OPP]@_9[\+:Y<
M?MD>(_"-XU]_PB?P8N;_ %C2YI9&:+4Y]?;[1;!2&X;3XCJ=MY;_ /+*\MF
M& :^J=O-8G@CX;:'\.%U3^Q=/BL6US4)-5U"0,SR7MU(%5I9'8EF;8D:#)PJ
M1HBX55  /GWXV_:/"O[4FFW_ ,-+'X@1^.-9UC2;7Q58#P_>-X1\1Z4SPQ7-
MU<W<L0LX[FUL3*\<MO.D[O;PP2+.@2$>4:?\.K/X;?"3_A!;+X/Z/::/<?$S
MQ1<:[-J'PMOM>L+:)]1U&?3)(["U6/[6LMK-"J7*,\-NJA'VN54?>NT;L]Z
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M5Q8V\VK:1%/!973+F2VCF\OS54]@_E1Y]=@H ^$?!WPJ7P_IUC_PNCX<^/\
MQIX+E\-7EOX$TJ'1+W7+OPVK:UJDT%M+' 'DL[_^RI=#ACNI64Q-9S+]HB8,
M9'>)OV-/%'Q._9C^-2?$+PK)XR^)T_PCL=!TV74XDOTGUC^P'2Z:S+YC\Z2]
MV!Y8\%VCBR?D7'WX4W4;* /!_P!H?0D\8_L6K;> ?#^MVN@/<:5+<:%8:5<:
M+J$VB1ZE;/J5I%:.L,\3R6*W2"':DC[]J@,PKQ*V^!%K\1_BM9V_A/P%XDT#
MX(7OC#197T*XT.ZT.TEGATW6!J-P=.E2)XK&7?I4$B21)#-)'*2CB1GD^Y\4
MC)N- 'C/[+_@*[^&WPZ\?>'H])N-+T73_$^JKX>L&B*0Q6,NV5$MUZ"#S))0
MBI\JK\J@*H \$\'?L]>*O /[#'P#L?%UQ\0_&WAC38_#K^//"-UID%Q<6FGP
MZ//$;1+.SMHI[B.+47L))X'$SO%:2*5D!>.3[AV\8I<8% 'P_P#"7]G1O'_Q
M=\/_ &KP7K]I\&XO&FLZMX8\/ZKITUG::=IXTC3DC2>PE53! VK1ZA<P6UP@
MV%H75(PL:))\(_V*=/U/Q!\++KQ-X'NKQM1NO$\GB_\ M.W>9-4C:ZDDL8M2
M63(N(8R5:WCG#+%L0QA<"OMS%-V"@#S']B_1]8T#]DGX=Z;XBAU*'6M/\/VE
MG>1:EO:[1XX@FV4OEV<  $N2Q/))))KQ6P^&GB;PS^SII.IS>'=<N9O!WQJ\
M0^++S2(;1GO+W3)?%&KLL\4(&Z;;;W<=XB("\JQ+Y:N[(K?70&* ,4 ?-_P8
M\/?$;Q?XG^('C+PE?6'@?1_&WC6/5HK;QAX/O+B]U#3H='TJPWK;_;+26QD>
M6RN2OVA';88F,2]#Y]^Q[\*?%G[,GQ&\0>+]4\*ZKK6E?$7Q[XIL;IVLGDUC
MPA%-XIU26QEAC R^D722Q3OL7?%+<?:&,D$C-:?:-)MH ^9O^"@VGWWC35?"
MOAF;P/IOB/P_J5AJ=Q)J5YX(N_%GV._3[-';6L45O+$+.69)KEA>3.L<?V;:
M64N&'B&G?L^?$+Q/^S=XZ\6:GX?\177Q.NM-\'VLD^IVDUU?OIJZ?HKZ_;VT
M7FPN9)TCOHID@EBDGDC6/>&1"OZ$D9HZ4 >!?L(>!_\ A ?AOXJFTZ9Y=+U3
M6FO=-T6+P+?^";+10+.VC>WM+"^=I(H9)(VF+#;&9IYF R6)^9/AW\-?B%\2
M=0U+6-)\%OX*US4O!#^(KO3]-\%7WA>Q3Q7I^I:=J%C8W4US*W]HRK*+F%KM
M$2.:)YMI=6*Q_HQMQ3=@S0!\)_$?P_XD\<^!M'NO$WP]>^B^*EQK7B^Z.N>!
M+[Q1=:'.WV6VT?3/L4$L8TV[_LU8A)<2NL<4]K,-P:4N+'P,\"_$S'@?5O$?
MAWQ5?:Y9^*=!U6]6_5_,=T\ FWN&>1OE4?;V:%W/ E<@G-?<I7(HVYH _,2X
M^'/C7QMX!\3W5G\-=:TZ#Q-X<T*\UW1?"W@C4/"3-J<.OV4]Q;HUU-ON[R*!
M[G_35$:LHW*YP1%[%X<^%UQ??'.'5/AQX)UWPQ\,_P#A+]$NK33KGP]=:+##
MJ<6GZPFH:BEE-'')!;NLVE1%S&B22PR, 2QD?[8\L9S3B,T ?%/_  3$^$&O
M>$/$^EZGX@FU+1?%5GX1_LSQEI;> -4T4:YJ[2VSM?7FJ7%Q-;:I<Q217BI/
M;DATO9&W;/+ 9\2-$\4>-_VX=,U+_A7]OIUUHOC>WLYKVU\$7CW5_H3:<T+W
M-QKID%K+:R&7:;-$=D(0NH*-)']LA<4A3/\ ^N@#YV_8D^!OAW1/V9_&'@";
MP=)X7M+CQ%XDT_5[%=&ETB.]BN-0NA')%)L03QO9R0!)H690H50P*;5\)C\'
M?&Z3P[8^+KBP\92>/I[1_@K<2*CI&ML;98CXI, ^7:-7C>82X_X])=W3%?H!
MBC;0!\->./@1XX\$^+/$7AOPWHOB<>#O@S?M\3/!JVCRL=9GE>VG_LB.7.9W
M=D\16[Q-D1QZE9''"$.O/V>_&FN3:)I]]I?B9]/_ &C]-:'Q_L>6-?#"KJ,V
MJM;2NI#P^9I]]?Z9YH*L&M[)01A=OW&5R:0H#0!\T_L7W?C2PO+K6OB7I_B?
M_A)KJ6R^'D$KZ=*T5\NDVUR\VL,%!$$%Y=O>,DK[5=/L8R2Z _*WP<^'=YXW
M_8O\"S?#_P $^.+'QS-\']6C\9ZO/IEU&_B07.AD6D(O64)J,LEZUO+;>5)(
M;>*.1,PA_+;]/PN*S?!W@W2_A]X3TO0=%L;?3='T6TBL+&T@7;%:P1($CC4=
ME50 !V H ^*_BY^SEX7^'7BS7].UWX9^+O%&@W7@:TM_ PT/1;K4IK+76EOG
MU&99X58V&J7$TEA*VI7#0EV"L;@&&0BQHOP'\9>+?COIH\>:3XDU+P/JUC%X
M?\51V330PWWBQ]$^S7'B*.-55UT\P-)8AE(3[0T<_DCRQ<C[?Q5;5-)@UG3+
MFSN%=H+R)H90LC1L48%3AE(93@GD$$=C0!\)_#X?$3Q'\-]0^-.IZ;XF\0>-
M/A+KEAX:@TS3E\Z7Q/:Z']JTS7+B"W4X>6ZGO=8:.,<R?8K X#* M+QI^S_J
M'@K1/$6G_$KP;XN\?^+M4\$V[^$M0T#3;O4HM.\2W$E]<ZH;2YC4KI-P^HW$
M<BW4KP((?LRB7;;,(_NSP/X%T?X:^$K#0=!T^WTO1]+B$-M:P+A(UZ_4DDDE
MB26)))))-:NS% 'P-\9_@)XF\/R?&%=+\(M)\0/%&G>$=0U;6=)\+320>(-.
MAO+8>(($FA\D322PQ76ZR6>.>=64*,LK#VG]CC0Y/A;\-=8T_2KC4&B\9>(;
MJ30K2#X<ZIX5TKPJRZ;%F);&[9WM[5IK:6;>Q6-Y[MU3E@#]'[!3MO- 'P1X
M)^&VFP_LM>%M-D^&GC6W\4Z7>:(_QFAN/"U\=9\611LWVW.H>3C65%[MN)4M
MII_/MDEC59%F6%]7X;?LWV_Q'^,>E0_\('KEO\$Y/&&IWVC^']8TJ>QT^&T.
MA6L4GF:;,J?9[234EN9([:>)%,RF=4P\;'[B Q2;: /CS]D_X'7_ ,"]9^%.
MOMX:\16MXW@WQ!#XMNY(+BYO[QTN-/>RANV;=+/)'''*ENKEF1 Z1X4L#]<:
M!K*>(=#L[Z.&ZMTO8$G6*Z@:">(.H8+)&P#(XS@JP!!!!Y%6]M 7;0 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ^)?VX"HW>"OV4P>^/&NO_\ RJKZLHH \?\ V;-5^/VH:UJJ_&#0?@_I.G+
MATU_!NNZCJ,\DNX[Q,MU:0*J!=N"I8DDY '-<C\3->_:ZMOB%K,?@WPI^SC>
M>$UN6&DSZSXKUFVU"6#C:9XXM.DC1^N0CL/>OHZB@#YY^$6N_M877Q(TF/Q[
MX5_9YL?"#2L-3GT#Q3K%UJ44>QL&&*;3XHW;?L!#2*-I8YR #T'[26K?M"Z?
MXKT]?@_H'P9U;0VM,WTGC'7]2T^Z2XWGY8TM;.=&CV;3N9@V[(QC!KV:B@#Y
M3E\2_MP>4_E^"_V4]^#MW>--?QGMG_B55[9^T7>_%*Q\"VLGPDTWP#JGB8WJ
M"XA\7ZE=Z?8BUV2;V62U@G<RA_*PI0*5+Y8$ 'T"B@#Y5_X27]M['_(E_LJ_
M^%IK_P#\JJ]I\(WWQ5E_9ZFGU[2_A]#\5OL5TT5C8:I>2^'C= R?9E:Y>W6X
M$3#RO,80%E)?:K8&?0:* /E4>)?VWL_\B7^RK_X6NO\ _P JJ]8_9FU+XV:C
M;ZS_ ,+DT7X6Z/,CP_V2/!FLW^I+*I#^;Y_VJUMRA!\O;LW9RV<8&?4J* /F
M7Q;X@_;(A\6ZHN@^$?V9;C05O9QILM_XNUR&[DM?,;R6F1--=%E,>PNJLRAM
MP#$8-=!\"-:_:@O?B5:Q_$[PU\!=-\'F&4W,_A?Q+JU]J0EV_NPD5Q8PQ%2V
M-Q,@('0$U[U10!X;^T'K/[2UC\0?+^%/AOX&ZIX5^RQGS_%GB/5;#4/M&6\P
M>7;6,\?E@;-IWY.6R!@9Y#1_$?[:3ZU9KJ'@W]EZ/3VGC%T]OXRUV29(=P\P
MHK:6%9PN2H) )P"0.1]0T4 >9_M+:C\9-/T72F^#NC_#/5]0:X<:DGC+5[[3
MH8X=ORF%K6VG9GW=0P4 =R>*\B'B7]MW_H2_V5O?_BM->_\ E77U310!YWJ%
M]\6!^SFMQ:Z7\/&^+GV"-FL9=4O%\-_;-P\Q1<BW-SY(7=M;R-Q(&5'./&?^
M$E_;>_Z$O]E7_P +37__ )55]544 >;_ +.-]\7=0\*7[?%[2_AUI.N+>XLH
MO!VJWFHVCVOEI\TKW5O XE\SS!M52NT*=V20/'Y_$G[;8N9/+\%_LKM#O.PM
MXTUX,5SQD?V7@'&,C)KZHHH \3_9TUC]HZ_\<72_%OP[\$]*\-+8NUO+X0\0
MZGJ%\UWYD>Q6CNK*",1&/S26#E@P0!2"2,OXV:W^U/9_$_5(_ASX9_9_U+P6
MOE?V=<>)/$^KV6J/^Z3S?.B@L)HEQ+Y@7;(V4"DX)('T!10!\U^ /$'[8$WC
MK1T\5>$?V;+7PRUY$-5FTKQ;K4]_%:[QYK01R::D;RA,E5=U4G + <UW7[3&
MI_';3[G1O^%-Z)\)=8A=9O[6_P"$SUO4--:)@8_)\C[+:7 <$>;NW[<83&<G
M'K5% 'RJ?$O[;^WCP7^RKN_['37_ /Y55[1\2;[XKV_P(@F\'Z7\/;OXG>1:
M&:SUG4[RWT$3$I]J"W$5O).44>9Y9,(+83<%R<>A44 ?*O\ PDO[;V/^1+_9
M5Z?]#IK_ /\ *JO:O@I>_%*\^$TTGQ&TSP#IOCK?/Y5MX;U.[O=)*C_4[II[
M>*4$_P >(SCMFO0** /E.+Q+^W!Y*[_!?[*?F8&[;XTU_;GOC_B55Z9^S5JO
MQ^U'7=4'QBT'X/Z/IBP(=-;P;KNHZE/+-N.\3+=6=NJH%VX*EB3G( KV"B@#
MYQ^)NO?M<VWQ"UB/P;X4_9RO?":7+#2I]:\5ZS;:C+!_"9XXM.DC1^N0CL/>
MK'PAUW]K"[^)6D1^/?"W[/-AX/:5O[4N- \4ZQ=ZE''Y;;3!%-I\4;-YFP$/
M(HVECR0 ?H:B@#QG]I/5OVAM/\5Z>OP?T#X,ZOH;6A-])XQU_4M.NTN=YPL2
M6MG.C1[-IW,P;=D8QS7G,GB7]N#8VWP5^RGNQQGQKK^/_357U910!Y_^T3>_
M%2P\!VLGPETSX?ZIXG-Z@N8?%VIW>GV"VOER;V22VMYY#*)/* 4H%*ER2" #
MXJ/$O[;W_0E_LJ^__%::_P#_ "KKZJHH \]\(7WQ6E_9ZFGU[3/A[!\5_L5T
M8K+3]3O)?#QN@9/LRM</ MQY1'E>8PAW*2^U6P,^+CQ+^V_C_D2OV5<\?\SK
MK_\ \JJ^JJ* /+/V9]2^-FHPZU_PN31?A;H\BM#_ &2/!FM7^I"4?/YWGFZM
M;?81^[V[-V<OG&!GSKQ=XA_;(B\7ZLN@^$/V9[C0%OIQIDM_XOUN&\EM/,;R
M6F1--9$E,>TNJLRAL@,1@GZ8HH \$^!>M_M07OQ(M(_B9X9^ NF^#S%*;J?P
MQXEU:^U)9-A\H)%<6$,14OC<3("!G )XJS^T%K'[2UA\0?+^%/AWX&ZIX4^R
M1GSO%GB+5+#41<Y?S%\NVL9X_+ V;6W[B2V0, GW*B@#Y>T7Q'^VF^MV2ZCX
M-_9>BTUKB,7<EMXQUV2=(=X\PQJVF*K.$W%06 )P"0.:]4_:5U'XR:?HVEM\
M'='^&>KZ@UPPU)/&6KWNG0QP[?E,+6MM<,S[N"&"C'.<\5Z;10!\K#Q+^V[_
M -"7^RM_X6FO?_*JO9=0O_BP/V=%N+72OAXWQ;^P1,UC+JMXOAS[9N7S%%R+
M<W/DA=VUO(W$XRHY->B44 ?*I\2_MO8_Y$O]E7I_T.FO_P#RJKV3]FZ_^+6H
M>$[YOC!I7PZTG7!>$647@[5;S4;1K;8F&D>ZMX'63?O&U5*[0IW9) ]&HH ^
M6+CQ)^VTMS*(?!O[+#0[R(V?QEKRL4R<$@:60#C&0"<'N:[K]G35_P!HZ_\
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MQY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\
MQ-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@J
MU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?
MEJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30
M'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17Y
MM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7
M_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6
MK_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V
M/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]
M?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__
M ,30'*?I+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I
M+17YM?8_^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_
M^"K7_/U^QY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^
MQY^6K_\ Q-'V/_@JU_S]?L>?EJ__ ,30'*?I+17YM?8_^"K7_/U^QY^6K_\
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M_P"%?ZP,CT-I(#4G_!(&VCMO^"5_[.PC58PWP[T1B%& 2UE$Q/U))/U-0_\
M!9'_ )12?M$?]D_UC_TEDJU_P2'_ .46'[.O_9.="_\ 2"&@?0^BJ***!!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEQ\#_B/;> ?#L2336UO="X,2)=:A*6?8J-+EO+"YPJC!;(^N?V)/&'QB\<^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 (W2OS?OCC_@ZLL_\ LWP_^G=Z_2!NE?F_?'_CJLL_^S?#_P"G
M=Z 1^D-%%% !1110 4444 ?-?_!9'_E%)^T1_P!D_P!8_P#262K7_!(?_E%A
M^SK_ -DYT+_T@AJK_P %D?\ E%)^T1_V3_6/_262K7_!(?\ Y18?LZ_]DYT+
M_P!((:!]#Z*HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!^;_[-'P<_::_X),W/C_X>_#_X+Z/\
M??A3KGB>_P#%'A*_LO&MGX>U/0TO'\Q]/O(KQ=L@1ONRQ$YY)'SA(_9/V)_V
M:_B#\.?^"DW[6/Q.\5^'8=$\-_%M?!LV@2)J,%T9WL=$%M>H0C;U\J?*!G1-
M^-RY!KH_&7_!5SX6^!_^"ANA_LTWR>)/^$YUVVBD&HI:Q'1;&YFM[BYAL9YS
M*'2YEAMV=$$9#!T ;)('T1K'B[2_#R3M?ZA8V*VL0GF:XN$B$,9.T.VXC"EN
M 3QGB@#\X/@;_P $\/B]X,_X(/?&KX)ZCX7AM_B5XOD\5MI.E#5+1UN1?74L
MEMF=9#"F]74_,XVYYQ4H_9-_:"_9%_:5^"OQK\ _#72_BC/I_P #=-^$_C#P
MF/$UII&H:9/;/'="Y@N)LV\JB4>6P#= Q ;*E?T=O/$NGZ>D;37MI"LT33QL
M\RJ)(U&YG&3RJ@@D] "">*2V\4Z;>:7:WT6H6,EG?%5MYUN$:*<MT",#AB><
M8)SB@#\_/V5_V4_C-\ _V9/V@/&7C7X+^$?B9\0OC_X_F\47WPM/B.T%C::9
M/Y,/V26]N(C;32Q1K)(1MV281=P))&M_P15_88\>?LG>/_CEXBUKP'9?!/X>
M_$34M.N?"OPPM?$HUY?#LD$4JW=V98\PQFY=T/EQ,<",*<!$K[T75;5[V2V6
MX@:XMU#RQ"1=\0/0LN<@'U-<!\>OVC]*^#G[-/Q"^)&G?8_%%MX T#4-;EM+
M2_0"Z-I;/.8/-4.$9@FW)!QG.#0!\<>*_P#@C_HG[47_  5S^,'Q'^-'PUTK
MQ;\,=4\.:#!X6GO=2#137UO&5N5>UBE#$#"_ZY"AQQGFN@^*G_!+K2?CI_P5
M\T_QGXT^$_@CQ5\"]&^"EOX3TV#5;*QN[&PU>#6))HHH;)\M'LM)&"R+&$"L
M5!SQ7U%\%?VDK7XK?L=>$_C!<:7<:98^)/!MGXQDTV.9;B:TCGLDNS '(179
M5?;N(4$C/ /'D?["W_!7OX4_M^_L_>./B1X;A\5>%=$^'9:37+;Q-9P6MY;6
MPLDO5NPD,TRF!XF?:V[),,G& "0#XYU/_@ES\</ W[-W[47PD^'/@71_!_A[
MX^?&&"VTZ:PU&PM;70?!<R1+=WD<"2#:@AA:#[,%\TB<X3 R/0I/^"4_Q@_9
M._;3_9Y^+'@'Q]XH^,EKX-9? 'B+3->31](.D>$98F0&$VT-L)DM9-LPB;>[
M,D>P??S]-?\ !.'_ (*A> _^"G/PP\2>+/!6A^-/#6G>%]233+R+Q1:6UG.7
M:VBN0ZK#/,OE^7,ARS ]>,<GZ%T;Q'I_B/2H[[3KZSU"QDR5N+:998F X.&4
MD<8]:!GX[>"O^"+_ ,5O@G\)5^,'@_X>:/:_M.>!_C;J'B[3%35[2.;Q;X8N
M+PJ^GS7/F^2J26\K.%D8,FQE&TN0?7/VI/\ @FE\7/BY\:/VQ?&WA_0;:RUS
MQ)J/P^\:_":]GO[4R7&M>';4,Z8\W]PQ</;[I2JD3E@VT;A^A_C'XY>$? ?P
MKUKQOJ6OZ<OA3P[9W%_J&I02?:HH(8$9Y2!%N9V55/R(&8D8 )(%<'HO[8,?
MQ,TWX/:]\/?#5YXW\%_%A5NI-<AOH+(>'[.2T6YAGGMYBLSEPZ+Y2+YB%OF
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MA=H-M\,+JX\,WNO:;;7'V<G5K.&.WBD%OJ<UR5=68(^T##@%17Z\>+O%VE^
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M$&(('C8AC(3G( _6 ]*Y/X7_  >\&?"(>((/!^@Z'X?_ .$@UFXU[6DTRW2
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MG_@H9JW[=OAGX@6?B*U\/MKOPZUQ--;6?#EM>V^B^([6:!9K>[MH[Q1/$?\
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M,\*2.L\4RPO(&C=R X0AF4L!ZYHW_!#SP#H_[.7A'X=?\+(^,EPOPSUI-:\
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M6VG:<'.#Z4>>GG^7O7S-N[9GYL=,X]* '4444 %%1M<QK<+"9%$LBEU0GYF
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M>'=6C\0:%\4OAE<ZYJ&HPVK6L-Y+I]UIB6=R(&YA>:/5;L,KX?%O&ASY.%]
MU_\ 94\%^*]7U&XU+2Q>6NJQ6:W%B\A%OYUJDL45RH&&6<PRF%GW9>*.-#P@
M%:W@3X(^'OAIXDNM3T>QAL?,TRQT.TM;>)(+32M.LQ)]GM+>% J1Q*TTK8 S
M\X&=J1JH!\__ /!0(:[:?M!_"76O#DFJ3:QX(TGQ#XKM-.LYF']LFT;3!<69
MC!V2-<64UY;Q[P1'+<)(.4%<;X\^)WB/X[_M<>'_ !O\.-6M;RWAT?Q%X<\
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MO'FF7GV#3X+*?3-8N='BT=[Z:7SUNK<6Z75Q\L1BA=9"RY6Z5"&:)I'[.?\
M9\\#W-YI-Q)X5T-I-#TF30;+-JNV'3W01M9XQAH"H \M@5]JYV7]C7X?VG@N
MV\.Z/H<'AS18-9TS6Y+72PL"7,FG7$5S:0OP3Y"2PQ8B7:H5-HPI8$ ZSXT?
M$:Q^$7PF\1>)]3U%-)L=#T^:\EO'LY+P0;4)!\B,B28[L8C0AW.%7DBOF#3_
M -KCXK*NN>&9$L+'Q-9^+O#FCV]YK^C112166J\2/);6E[*IDCV2/&#+&Q#(
MKH,%W^MO%7A32_'?AG4-%US3;#6-'U:WDM+ZPOK=;BVO(74J\4D;@JZ,I(*L
M"""0:Y?PG^S/\/\ P+$RZ3X/T&S:2[M[^65;13-<7-N28)Y)#EY)(]QVNQ+
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MPR80@;'4]"* /F6X^)WB;X2?LM>"O'TWB;5-%\,Z6VNZY\2X=&DT]-:COSJ
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M^!27VCS^-M5\'W\VFZG+#I5QJ%B+P6=_#=M92)#(8V$=PMU"T.U2'WIM'.*
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MO"^N>--7\#S6FN3:4;"2YL='U&:9[>VBB%\(X;NRC9I)[A2RNX"&.2%QZ?\
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M^D:!X]T#P)K%AJ-SI4.EWMSJ*V<DD5M!Y#7\TBVM_%/O\Z)5:/*AXUD5Z?\
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M:AXETW3EDC-M;1VSQZA:75Z\(DC?:UB[(64[5V+3Q[\0_A]XR\17-U\3M?\
M$&G^"?BGH?@6#3[_ $_34CU2PU*'26E:[>*V21KB-]6?RWA:$!;6W#K(3.TW
MT7\,--\![_%&B>%=)T*R_L'70FMVMEI:VL::FT%M>B1@$59)3'/;2>8-W)7Y
MMRD#J6\.V+O*39VC>=.MU)F%3YDR[=LK<<NNQ,-U&Q?04 ?'?PZ\5?%#XB^(
M_ATMS\7_ !'9V_Q$UCQ/97\-GI6E*+"VTZYN1:+9E[5BDNV*-97E,P<-+M6,
MF,Q8?A_]J'QA\1_ .H7NN_&)OAO+X,^%FG^+4OHK#31#K=T\NHQ75_=I<0/O
MMXVLK93#:F#:;F3+?O;<Q_;&I6VB^%=+DU*\72]-L='BFNGNI@D,5BF"TTA<
MX$:XW,S9 QDFJVK?"KPSK[Z.U]X=T&\;P]<"[THSZ?%(=,F!R)(-RGRGR!\R
M8/O0!\E'XZ?%37]&\8>/+WQ5JOA.3PGXH\(V'_"&C3[)K2WCOK+0IM0M+J22
M W#,6U&X5622-HV"GY@-M>M?M\^.?$_PN^'5OXHTGQ!J6B>&?#,-YJWBI-&G
MTZ'6I+"" NTUJ;^*6W<0',CQ-Y9< 8DX,4WJNJ:[X;MO'UIX5NELSK?B2TN=
M;BM6M-WVR*RDLXI9F;;MW1M<V:C<=WS+MR$.VUXP^&OAWXARZ?)X@T'1=<?1
M[E;RP;4+&*Z-C.OW98BZG8X[,N",=: /CW5?B#KWPU\0_&O5+#XF^(+6S\1?
M%+P]H\FH7\&G&/PE87^FZ(3<Q1M:C8V)Q:QFXWQHS1R2)(XE,EU_C_XLM?C
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MXD^'?A&?1W;2[F8ZK-:V4\-Q90"-&,EZC>6?LR@S,)4*HW..=^%T-_\ LE>
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M?'OPG\?8/$DGA/4VU2/PGKMSX;U-OLTL*P7UN$,L:F15\Q0)$(D3<C _*QH
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M&\MX]ES:SR6]Q'A@,[98W7/0XR"1@T ?G?X;UCXG:S\%/B'JA\<:IH_Q,M?
MGB(^)M#M/$.K7FM6NJMM\B:"PF006 M[@,+9[8&.:!QL\U"''M?Q4^'=G\/?
M'7Q4T'_A.+_P';W'@[PS+I7B'6=;OKC_ $6#6-1DNX9+N2X6Z*F6X6*XF2=7
MBBU"WQ(F(\?3U]\3M-L/BQIO@QTNO[6U32+K6H65!Y(@MIK:&0%LY#;KJ+ Q
M@@-R,8.Q<>'[&[UNUU*6SMY-0L(Y8;>Z:,&:".4H9$5NH5S'&6 X)C4G[HP
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M_P!0T?5OA;>36'B35/%^KZ1<ZUX"G\1ZE#=37@&G0PHLBKI;SP-YJW-R46/
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M>O+3PY9IKFH?&;3_ !E'<K) LS64=S9QRW6_=\K?8DN(RN=[(SIM.\@_4%%
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M^*_&5GXVTB[\0V5MX:\+:AJU]::99S?9[R\N[>&%I+:*"?,+^:%;S%9%5F!
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M)7@GX]^/?#=F/#;:;X;^/G@#X;6A>P<R'2M:MM.EO"Q\SF;==2;'P O&5;%
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M+0_#>@7FN:KJ(MT$ES*EM:QO(8X(V#R-C@$8R2 ?EG]C[_@K/J'Q:^'GP?\
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M0N_ _P"PQ^S]\&V\>V]S-\$/B!I/C>75AH[(NLK9:K-J!MA%YY,)?S?+WEW
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MV.F^6)S@+::=%%YF\@,[OLYVUVNH?\%HO!.A^"[YM4\"?$#1_B%I_C8^ )_
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M ?!6L_#_ %?6?$'AJ35AJ6EZE>QWI-K&;U&MY+5XHX[?S9;A%CCC5UDVD/\
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M^QS_ *L($_LO_7?>XSY_3_IG7V=10!\!^+O^"+_B#5(;S[#\2/#=Y;WGQ?\
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M-,TO1X+?1)G!4Q)96L06X5-P,K[V<N2>%15^V** /C/P[_P1D\*ZGH5OIWQ
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M  M'Q_\ %/Q(L+6L>OW6A:E';F7S/(6;P_I\NP-@9QOQD 9ZXYH ]^HKX=^
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M=0MK#4-/LI/^$P?^SS>-=:B?)5EM[AU>UC%D("LMO<L#)\L4?L?[6WQ&\2^
M?V>TU;PK-:Z1XDO]:T#3+:34+;[3%:F^U>RLY/,C!&X!+AP0&!]"#@@ ZBX^
M 7@VY^"UM\._^$?L(_!5C8P:;:Z3"#%#9V\ 40)"5(:(Q>7&8V0AHS&A4J5!
M&=X0_9I\!_#.X74+'188;FUU4^(9+^[NYKJZDO\ ["U@UY-<3.TDLOV-FA,D
MC,=F 3\HQX#X7^,'QFUC]HO7-!T0>*O$VE_#GQ7I/A746NH/#\&GZA8RVEA/
M>ZC>L)8KU+P1WLDT0M8$@988D\IS(SKR$/[4'CZY^'/PR\67WCS3=4_X6[H'
MB'5-1\'W.DV30:&UMI-S=+:0%8Q-MM)E2VNA<M*7E _U(+1$ ^M/ /[/7@[X
M?>,;[Q)X=L[K3[C6);B[FAM]5NO[,>6Y<2SSI9>:;5)99/G>1(@[L[L22[$[
M&O?"+PQXIG\12:IH>FZE_P )=I::)K4=U")HM4L4$X6WF1LJ\>+JX!4C!$K
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MI6@:3\*/!.G^'= 72]$ACC:QT6TF<B$RB-Y%C49W/@([%5.[:C'L2/._A?\
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MQXC_ &R-*M9H;&./0_B]>65NUO:I"\J-X"2?=*RC,DFZ=QO;)VJBYP@ ^L*
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MZD6.*=O[3'CVS\#?M%6/BR:[U?6/!/B;1+:Y\/:YI_CF/PV?$&GQ::HL-/\
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MBWT<6C0:FUP[ZE;K.TQ>.2) AA,1+^]?MG!AX+\&R3L5T2'QYX=?5B,Y$?\
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MAUX/BU5[>WUNPD@L&54TX,([^WN)I;U)[MXY&MPDVV2'[+N4 ^P_'?P]\/\
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M\8>.-7?4OBGXF\$S6NIZM-=6J:)9Q:X+2!HG)5Y%?3[63[7(&NI"S!YG1MM
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M?".FWGCGX*ZXVEV,VM6/CZQM(=0-LK75O;R13M+$LN-RQNT<9900"8U)S@4
M>V7NA:=/J]MJMQ9V3W^G12Q6]Y)$IFM8Y-AE5'(RJOY<98 @'8N<X&,7X/\
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M $;I7YOWW_*U99_]F^'_ -.[U^D#=*_-Z^_Y6K+/_LWP_P#IW>@$?I%1110
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M#%%% !1110 48Q110 4444  &#]>OO1110 48HHH ,4444 &*.E%% !1110
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M8_\ 262K7_!(?_E%A^SK_P!DYT+_ -((:J_\%D?^44G[1'_9/]8_])9*M?\
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M+)5K_@D/_P HL/V=?^R<Z%_Z00U5_P""R/\ RBD_:(_[)_K'_I+)5K_@D/\
M\HL/V=?^R<Z%_P"D$- ^A]%4444""BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!&Z5^;U]_RM66?_ &;X?_3N]?I"W2OS>OO^5JRSZ?\
M)OAZ_P#87>@$?I%1110 4444 %%%% 'S7_P61_Y12?M$?]D_UC_TEDJU_P $
MB/\ E%A^SK_V3G0O_2"&JO\ P61_Y12?M$?]D_UC_P!)9*M?\$A_^46'[.O_
M &3G0O\ T@AH'T/HJBBB@04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 (W2OS?OCC_@ZLL_\ LWP_^G=Z_2!NE?F_?'_CJLL_^S?#_P"G
M=Z 1^D-%%% !1110 4444 ?-?_!9'_E%)^T1_P!D_P!8_P#262K7_!(?_E%A
M^SK_ -DYT+_T@AJK_P %D?\ E%)^T1_V3_6/_262K7_!(?\ Y18?LZ_]DYT+
M_P!((:!]#Z*HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH@(X6N'F,4?R+A20=/\ :1_X)G^#_P!J7X1^'_A[XC\6?$2U^'NCZ3;Z)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $;I7YOWQ_XZK+/_ +-\/_IW>OT@;I7YOWW_
M "M66?\ V;X?_3N] (_2&BBB@ HHHH **** /FO_ (+(_P#**3]HC_LG^L?^
MDLE6O^"0_P#RBP_9U_[)SH7_ *00U5_X+(_\HI/VB/\ LG^L?^DLE6O^"0__
M "BP_9U_[)SH7_I!#0/H?15%%% @HHHH **** "BBB@ HHHH **** "BBB@
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M_!O_ ,*NS_\ CE'_  ^%_95_Z.)^#?\ X5=G_P#'* /I"BOF_P#X?"_LJ_\
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MS_\ CE'_  ^%_95_Z.)^#?\ X5=G_P#'* /I"BOF_P#X?"_LJ_\ 1Q/P;_\
M"KL__CE'_#X7]E7_ *.)^#?_ (5=G_\ '* /I"BOF_\ X?"_LJ_]'$_!O_PJ
M[/\ ^.4?\/A?V5?^CB?@W_X5=G_\<H ^D**^;_\ A\+^RK_T<3\&_P#PJ[/_
M ..4?\/A?V5?^CB?@W_X5=G_ /'* /I"BOF__A\+^RK_ -'$_!O_ ,*NS_\
MCE'_  ^%_95_Z.)^#?\ X5=G_P#'* /I"BOF_P#X?"_LJ_\ 1Q/P;_\ "KL_
M_CE'_#X7]E7_ *.)^#?_ (5=G_\ '* /I"BOF_\ X?"_LJ_]'$_!O_PJ[/\
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M5=G_ /'* /I"BOF__A\+^RK_ -'$_!O_ ,*NS_\ CE'_  ^%_95_Z.)^#?\
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MV4_^C=O@[_X2MI_\11_PYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\ #G3]E/\
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M[_X2MI_\11_PYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\ #G3]E/\ Z-V^#O\
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M_$4?\.=/V4_^C=O@[_X2MI_\17TE10%V?-O_  YT_93_ .C=O@[_ .$K:?\
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MYT_93_Z-V^#O_A*VG_Q%?25% 79\V_\ #G3]E/\ Z-V^#O\ X2MI_P#$4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
>HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
